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Abstract  
Water is essential for life, yet access to safe drinking water is still a major concern worldwide 
due to waterborne diseases. The current study proposes silver nanoparticles (AgNPs) as an 
antibacterial agent. Silver nanoparticles were synthesised using different reductants and 
stabilisers, and the resulting structures were characterised with Ultra-violet visible (UV-vis) 
spectroscopy, transmission electron microscopy (TEM), energy-dispersive spectroscopy 
(EDS) analysis. The antibacterial properties of the AgNPs were tested against a panel of 5 
indicator organisms: Cupriavidus metallidurans, Staphylococcus epidermidis, 
Mycobacterium smegmatis, Bacillus cereus and a multi-drug resistant Escherichia coli 1699. 
 
Spherical AgNPs that absorbed at around 400 nm, with diameters ranging between 18.8-26.4 
nm or 5.4-13.1 nm were prepared by ascorbic acid or sodium borohydride respectively. The 
optimum processing conditions that produced 6±1.8 nm spherical nanoparticles included 
maintaining the temperature at 0 ⁰C, the pH at 9.78 and the NaBH4/Ag/PVP ratio at 16:1:10. 
Exposing AgNPs to light for 6 hours did not alter the particle size rather it changed the 
particles shape from spherical to icosahedral. Stirring caused particles to agglomerate, 
however, no agitation resulted in the formation of irregular structures of different sizes. 
 
Sensitivity to the AgNPs ranged between 25 % and 100 % reduced bacterial growth 
depending on the strains used and the concentration of the AgNPs. The Gram negative 
bacteria were more sensitive to AgNPs than Gram positive bacteria. However silver ions 
were more toxic than AgNPs for all but one of the strains tested, B. cereus was completely 
resistant to both Ag
+
 and AgNPs. C. metallidurans and E.coli (1699) showed a dose 
dependent sensitivity to AgNPs and the minimum inhibitory concentrations were established 
at 50 and 20 mg/L AgNPs respectively. C. metallidurans and E.coli (1699) were also 
eradicated by 10 mg/L Ag
+
. The E. coli TEM images showed accumulation of AgNPs within 
the cells, cell shrinking and leakage of cellular components. This suggests that AgNPs have a 
similar toxicity effect on bacterial cells as Ag
+
.  
 
Keywords: safe drinking water, waterborne diseases; water disinfection; antimicrobial agent; 
nanotechnology, nanoparticles, silver nanoparticles; redox reaction; stabilising agents 
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Chapter 1 
LITERATURE REVIEW  
1.1. Introduction  
This chapter accentuates the problems arising when people utilise unsafe water and the 
consequences thereof. It further addresses emerging pathogens; their resistance to 
antibacterial agents and the inefficiency of conventional disinfection methods. An innovative 
nanotechnology as a disinfection method is presented. The chapter further reviews the 
general literature on synthesis, characterisation and application of silver nanoparticles. The 
problem statement, the objectives and research question of the current study concludes this 
chapter.  
1.2. Water stress and scarcity 
Safe drinking-water is essential to sustain life and its availability may have tangible health 
benefits (Eisenberg et al., 2007). Hundreds of years ago water was available in abundance 
and considered an infinite resource in a world with fewer inhabitants and minimal pollution. 
The negative impacts of modern civilisation and industrialisation such as global warming, 
population growth and pollution have contributed to bringing about water stress and scarcity 
(Rijsberman, 2006; Gleick, 2003). A water stressed region is defined as an area that has an 
annual water supply below 1700 m
3
/capita/year. Water scarcity results when the annual rain 
fall of a specific region is insufficient to sustain its population (Jiang, 2009; Rijsberman, 
2006). Water stress and scarcity may occur as a result of natural causes such as climate 
change. Two thirds of the African countries including South Africa are already characterised 
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as water stressed with an annual water supply of 1000 m
3
/ capita/year (Rijsberman, 2006). 
The World Resources Institute estimates this to increase, that 48 % of the world's projected 
population in 2025 will be living under water stress and scarcity conditions (Rijsberman, 
2006; Johnson et al., 2001).  
1.3. Waterborne diseases 
Appending to the burden of water scarcity, 60 % of Africa’s open water sources are regarded 
as unsafe resulting in over 1000 deaths per million population annually. The World Health 
Organisation (WHO) defines safe drinking water as: water utilised for domestic purposes that 
presents with microbial, chemical and physical contaminants below the WHO guidelines or 
national standards on drinking water quality (WHO, 2011; Eisenberg et al., 2007). 
Consumption and utilization of unsafe water may result in waterborne outbreaks. A 
waterborne outbreak is defined as an incident where a number of people suffer waterborne 
illness with epidemiological evidence linking to a common water source. Microbial pollutants 
exceed the other water contaminants and the consumption of pathogen contaminated water 
may result in a waterborne disease (Morones et al., 2005; Sondia & Salopek-Sondib, 2004; 
Lok et al., 2006; Goering et al., 2007).  
1.3.1. Waterborne pathogens 
Waterborne diseases are caused by pathogens transmitted into the body through ingesting, or 
by mucosal and skin contact, with contaminated water (Morones et al., 2005; Sondia & 
Salopek-Sondib, 2004; Lok et al., 2006; Goering et al., 2007). The infection can be 
encountered when bathing, drinking or using contaminated water when preparing food. 
Waterborne illnesses manifested by gastroenteritis-like symptoms include watery or perfuse 
diarrhoea, vomiting, fever and they may be severe, causing otitis, cholera, haemolytic 
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uraemic syndrome, renal failure and ultimately death (Goering et al., 2007). Waterborne 
pathogens comprises of bacteria, fungi, viruses and protozoa (Guggenbichler et al., 1999; 
Sambhy et al., 2006; Dibrov et al., 2002; Goering et al., 2007; Parka et al., 2009; Rai et al., 
2009; Rosarin & Mirunalini, 2011). The World Health Organisation narrows the list of 
virulent waterborne bacterial pathogens to include Burkholderia pseudomallei, 
Campylobacter jejuni, C. coli, Escherichia coli –EHEC, Francisella tularensis, Legionella 
spp., Leptospira, Mycobacteria (nontuberculous), Staphylococcus spp., Salmonella Typhi, 
Salmonellae, Shigella spp. Bacillus spp and Vibrio cholera (WHO, 2011). The aquatic 
environment, soil and vegetation are natural habitats for these organisms. However, these 
organisms are abundant in faeces of warm-blooded animals, hence faecal contaminated water 
is the main source of infection.  
1.3.1.1. Bacillus spp. 
Bacillus is a genus of heterogenic group of gram positive, endospore-forming, rod-shaped, 
facultative anaerobic bacteria. This endospore-forming ability permits the bacteria to tolerate 
harsh conditions better than the non-sporulating bacterial enteropathogens. Under stressful 
environmental conditions, the bacterium produces oval endospores that can stay dormant 
until the environment becomes comfortable and then they germinate to their vegetative form 
that is most infective. The bacteria proliferate in a wide range of environments including the 
soil, water and foods.  Some species are pathogenic to humans and are found in abundance 
within the gut of warm blooded animals; hence they are transmitted through fecal-oral route. 
Bacillus cereus is the most virulent foodborne pathogen of all Bacillus species.  B. cereus 
produces heat-labile enterotoxins and a heat-stable emetic toxin that are respectively 
responsible for the diarrheal and vomiting type of illnesses (McIntyre et al., 2008). Other 
Bacillus species such as B. subtilis, B. pumilus, B. anthracis and B. licheniformis have 
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generally been considered of little significance in food poisoning incidents but their ability to 
produce both enterotoxins and emetic toxin has been increasingly recognized (McIntyre et 
al., 2008; From et al., 2005; Apetroaie-Constantin et al., 2008). They have an infection dose 
of a million colony forming units per gram of sample. The symptoms manifest within 15 
minutes to 11 hours post infection and may last a day. Symptoms include vomiting, 
abdominal cramps, diarrhoea, nausea, headaches and sweating. The intoxication is usually 
self-limiting (McIntyre et al., 2008). The infection may be severe and cause bovine mastitis, 
severe systemic and pyogenic infections, gangrene, septic meningitis, cellulitis, 
panophthalmitis, liver failure, lung abscesses, infant death, and endocarditis (Apetroaie-
Constantin et al., 2008). Thermal disinfection may not be ideal in disinfecting endorespore 
forming bacteria since high temperatures induce the formation of heat stable spores and slow 
cooling may favour the formation of the enterotoxin.  
1.3.1.2. Escherichia coli 
E. coli is a Gram negative, facultative anaerobic bacillus. The bacterium is found in the soil 
and fresh produce but is present in abundance in the intestine of warm-blooded animals. 
Hence it is an ideal indicator of faecal contamination. Indicator organisms are non-pathogenic 
organisms that are present in abundance in faeces therefore are used to measure potential 
faecal contamination of environmental samples. Faecal contaminated samples pose a hazard 
due to the presence of pathogens that are transmitted through the faecal-oral route such as 
Vibrio cholerea, Salmonella typhi, and Leptospira spp. E. coli is normally harmless and 
forms the normal flora in the gut where it produces vitamin K2. Some serotypes, such as 
Enterohemorrhagic E. coli (O157:H7), Enteroinvasive E. coli and Enterotoxigenic E. coli, 
have gained virulent genes, through horizontal gene transfer, that cause serious food 
intoxication and food poisoning in human. Poor hygiene, improper cooking of food, faecal 
contaminated domestic and irrigation sources may result in foodborne illnesses. In 2006 E. 
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coli O157:H7 contaminated spinach and lettuce caused 205 foodborne illnesses that claimed 
the lives of 3 citizens in Atah and New Mexico (Grant et al., 2008). E. coli O157:H7 caused 
3,950 outbreaks of foodborne illnesses episodes and 53 deaths in northern Germany in 2011 
(Bielaszewska et al., 2011).    
1.3.1.3. Mycobacteriaceae 
Mycobacterium is a genus in the family of Mycobacteriaceae.  They are aerobic, nonmotile, 
straight or slightly curved bacilli. The bacteria have a long incubation period that can extend 
up to 3 weeks. Mycobacteria have a distinct waxy, thick, acid-alcohol-fast and hydrophobic 
cell wall rich in mycolic acid. Mycolic acids are interconnected to the peptidoglycan layer by 
polysaccharides and arabinogalactan. The cell wall also presents with high lipid content that 
accounts for hydrophobicity and allows these bacteria to adhere to surfaces easily and form 
biofilms (Falkinham, 2003). The cell wall makes a substantial contribution to the resilience of 
this genus. They are naturally resistant to a number of antibiotics that disrupt cell-wall 
biosynthesis, such as penicillin. Furthermore the cell walls aid in the resistance to acid, 
alkalis, detergents, oxidative bursts and lysis (von Reyn et al., 1993; Falkinham et al., 2001). 
The bacteria can be found in a number of environments such as water, aerosols, soil, mud, 
plants and can replicate in free-living amoebae (von Reyn et al., 1993; Falkinham et al., 
2001). The genus comprises of some non-pathogen strains such as M. smegmatis and other 
well known pathogens such as M. avium, M. intracellulare, M. leprae and M. tuberculosis 
(Falkinham, 2003). Over the years Mycobacteria were susceptible to the antibiotics 
clarithromycin and rifamycin, but antibiotic-resistant strains have emerged. M. avium is a 
potential pathogen occurring in drinking water systems and it is known to resist chlorine 
better than many other microbes (Torvinen et al., 2007; Taylor et al., 2000; Falkinham, 
2003). The incidences of M. avium and M. intracellulare infections have exponentially 
increased from 1.5 to 9.0 cases per 100,000 population during 1997-2003 in Canada 
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(Falkinham, 2011). The infections are mostly virulent to the immunodeficient (e.g., 
HIV/AIDS) and immunosuppressed (e.g. cancer and transplant) patients and elderly people. 
These bacterial strains dwell in household plumbing systems where they exist in biofilms 
(von Reyn et al., 1993; Falkinham, 2011). Taylor et al., (2000) concluded that M. avium is 
highly resistant to ozone- and chlorine-based disinfectants. 
1.3.1.4. Staphylococcus epidermidis  
Staphylococcus epidermidis are nonmotile, capsulated, gram-positive cocci that are 
approximately 0.5 to 1.5 micrometers in diameter that arrange themselves into grape-like 
clusters when viewed with a microscope (Mack et al., 1996). The normally colonize the 
human and animal skin and mucous membranes (Mack et al., 1996; Kalishwaralal et al., 
2008). S. epidermidis is normally a non-pathogenic bacteria and it forms part of the human 
skin flora. Opportunistically the bacteria may manifest skin infection and systemically spread 
to cause endocarditis or sepsis in immunocompromised patients. The bacterium has the 
ability to form biofilms hence the burden in surgical implants, contact lenses, prostheses and 
catheters (Kalishwaralal et al., 2008). The capsule comprises of polysaccharide intercellular 
adhesion (PIA) which aids the bacterium to bind to the already existing biofilm, which is an 
antimicrobial resistance strategy employed by the bacteria. The biofilm sanctuary protects the 
bacteria from disinfection and supplies these pathogens with nutrients abundantly, therefore 
allowing the microorganism to persist for longer (Lehtola et al., 2007; Steed & Falkinham, 
2006; Falkinham, 2003). Biofilm is a slime of bacteria communities living in aggregates in a 
mass of self-produced matrix; these cells adhere to each other on a surface (Guggenbichler et 
al., 1999; Furno et al, 2004). This slime is a polymeric accumulation of microorganisms, 
nucleic acids, proteins, and polysaccharides. Species which live in this community are more 
virulent and difficult to eradicate than those living in isolation (Guggenbichler et al., 1999; 
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Furno et al, 2004; Goering et al., 2007). Chloride and antibiotics cannot easily diffuse in the 
mesh of PIA hence the inefficacy in eradication biofilms (Stewart & Costerton, 2001; Mah & 
O’Toole, 2009). There are emerging strains that are developing resistance to first line 
antibiotics such as penicillin, amoxicillin, and methicillin.  
1.3.2. The burden of waterborne diseases 
Waterborne diseases claim approximately 1.8 million lives annually of which 84 % are 
children under five years of age (Tiwari et al., 2008; WHO, 2011). Tiwari et al., (2008) 
estimated that a child dies from waterborne diseases every 15 seconds in Africa. The most 
susceptible people are immune compromised patients, elderly people over 65 years of age 
and those infected with HIV/AIDS (Goering et al., 2007). The burden of waterborne diseases 
may be under-estimated in accordance with the absence of proper surveillance and abuse of 
broad-spectrum antibiotics, where antibiotics are administered without identifying the 
causative agent. Contaminated surface water may contribute other water related diseases such 
as vector-borne diseases and food poisoning, therefore broadening the mortality to 5 million 
annually (Gleick, 2003). Waterborne disease results in healthcare expenses and lost 
productivity days therefore threatening the food security, economic development and quality 
of life (Jiang, 2009; Rijsberman, 2006; Johnson et al., 2001).  
1.3.2. Risk factors that may escalate the burden of waterborne diseases 
Sewage discharge without sufficient treatment is the main source of organic impurities in 
surface water (WHO, 2011). Poor hygiene, improper water disinfection methods and open 
defecation increase the risk of waterborne diseases (Eisenberg et al., 2007; Tiwari et al., 
2008). The majority of Africa’s population has a low socioeconomic status and lives in the 
rural regions where open defecation is still practised (Tiwari et al., 2008). Improving water 
quality in recreational water and domestic-water supply in rural Africa is currently 
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challenging. Hence there are so many deaths resulting from waterborne diseases (WHO, 
2011). South Africa has improved the quality of drinking water and accordingly the amount 
of waterborne outbreaks has decreased (Kahinda et al., 2007). 
1.4. Antimicrobial agents  
Water contamination has evolved over the years hence water purification technologies such 
as distillation, reverse osmosis, ultra-violet light, slow sand filtration, rapid sand filtration, 
anodic oxidation, chlorine dioxide, thermal treatment, chlorination and silver based filters  
have been developed (Burch & Thomas, 1998). These techniques have disadvantages such as 
producing off-taste water; some of the compounds are carcinogenic, expensive and may 
contribute to climate change by using enormous amounts of energy (Burch & Thomas, 1998). 
Some methods are inefficient at eradicating biofilms, heat stable toxins and endospore 
forming bacteria (Burch & Thomas, 1998; Goering et al., 2007; Morones et al., 2005; Dibrov 
et al., 2002). South African municipal water disinfection infrastructures prefer thermal and 
chlorine treatment techniques as they are easy to conduct and cheaper (Burch & Thomas, 
1998; Momba et al., 2009). However these technologies also have disadvantages and the 
epidemiology of waterborne diseases raises global public health concerns about emerging 
pathogens that are resistant to the conventional water purification techniques (WHO, 2011). 
1.4.1. Thermal treatment 
Thermal treatment may stimulate endospore-forming bacteria to change from vegetative cells 
to endospores. Endospores are reproductive structures that bacteria form when environmental 
conditions are fatal to the bacteria. When the environmental conditions are comfortable; the 
spore germinates into vegetative cells that are infective (Goering et al., 2007). The treatment 
is also ineffective against bacteria that produce heat-stable toxins. The mode of action of 
these pathogens involves the production of heat stable toxins which can survive very high 
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temperatures and if ingested cause food intoxication (Morones et al., 2005; Dibrov et al., 
2002; Goering et al., 2007). The toxin attaches to the intestinal mucosa and causes massive 
loss of water into the intestinal tract which will be later lost by the body through diarrhea 
(Dibrov et al., 2002; Goering et al., 2007).  
1.4.2. Chlorine treatment 
Scientists have realised that chlorination is not effective in eradicating bacteria in biofilms 
(Furno et al., 2004; Lehtola et al., 2007; Steed & Falkinham, 2006; Furno et al., 2004; 
Goering et al., 2007). Some bacterial pathogens, such as Mycobacterium spp., Vibrio spp. and 
Campylobacter spp, form biofilms in water purification systems as a survival strategy 
(Buswell et al., 1998, Lehtola et al., 2007). Conversely chlorine interacts with salts and 
compounds that can be found in water therefore producing harmful by-products (Pontius, 
1990). 
1.4.3. Metal treatment  
Essential metals (such as calcium, potassium, magnesium, manganese and sodium) are 
required nutrients and function as catalysts for biochemical reactions, stabilizers of protein 
structures, bacterial cell walls and maintain the osmotic balance. There are other metals that 
are nonessential and have no biological role (such as silver, aluminium, cadmium, lead and 
mercury) and which are toxic to microorganisms. Silver is considered to be the most toxic 
element to microorganisms: Ag >Hg >Cu >Cd >Cr >Pb >Co >Au >Zn >Fe >Mn >Mo >Sn 
therefore is considered an alternative to antibiotics (Sondia & Salopek-Sondib, 2004). Silver 
has been used as antimicrobial agents in medicine for many years (Fox & Modak, 1974; 
Furno et al, 2004; Morones et al., 2005; Sambhy et al., 2006; Lok et al., 2006; Rai et al., 
2009; Parka et al., 2009; Rosarin & Mirunalini, 2011). These non-essential metals have a 
greater affinity to thiol-containing groups and oxygen sites than the essential metals. Bruins 
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et al., (2000) described the mode of action of toxic and non-essential metals to include 
covalent or ionic interactions of the metals with essential cellular processes therefore 
damaging cell membranes, altering conformational structure of nucleic acids and proteins 
therefore interfering with enzyme specificity, disrupting cellular functions, and damaging the 
structure of DNA. Silver is a broad-spectrum biocide that hinders cell replication and 
eradicates a wide range of microorganisms including fungi, viruses, bacteria and protozoa 
(Morones et al., 2005; Fox & Modak, 1974; Rosarin & Mirunalini, 2011; Furno et al., 2004). 
However bacteria have adapted to metals through a variety of chromosomal, transposon, and 
plasmid-mediated resistance systems. These resistance mechanisms include exclusion by 
permeability barrier, intra- and extra-cellular sequestration, active transport efflux pumps, 
enzymatic detoxification, and reduction in the sensitivity of cellular targets to metal ions. 
When metals are present in small quantities they are transported into the cell by nonspecific 
uptake systems (Nies & Silver, 1995). However, in situations where metal ions are in excess, 
synthesis of specific ion efflux systems can occur to exclude nonessential metals. 
As an example, C. metallidurans has two large plasmids, pMOL28 and pMOL30, which 
carry genes that code for heavy metal resistance which are expressed when the 
microorganism grows in a metal stressed environment. C. metallidurans mediates its 
resistance to heavy metals by trans-membrane transporter protein complexes, which export 
cations from the cytoplasm to the exterior of the cell (efflux) and reductive precipitation 
(Mergeay et al., 2003; Reith et al., 2009; Rojas et al., 2011). Some bacteria have cell surface 
electron-transport systems or enzyme-reducing systems that allow bacteria to detoxify and 
regulate the movement of metal ions by changing their valence or charge through oxido-
reduction in order to regulate and resist the metal (Wakatsuki, 1995). Reith et al., (2009) 
revealed that the C. metallidurans has the ability to reduce ionic gold to elemental gold 
therefore producing gold nanoparticles. Some facultative anaerobes have also been shown to 
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reduce Cr (VI) through their electron-transport systems containing cytochromes (Wang & 
Shen, 1995). Mullen et al. (1989) showed that  B. cereus grown in the presence of 1 mM 
AgNO3 could bio-remediate and detoxify 89 % of silver ions and produced colloidal 
aggregates that accumulated in the cell surface and occasionally in the cytoplasm (Mullen et 
al., 1989).  Other Bacillus species have also been reported to produce silver nanoparticles 
such as B. licheniformis (Beveridge et al., 1982; Kalishwaralal et al., 2008), B. cereus PGN1 
(Ganesh Babu et al., 2009), B. subtilis (Beveridge et al., 1980) but the mechanism of this 
reaction is not yet clear. The plasmid-mediated resistance systems have been shown to be 
transferable to organisms that are naturally metal sensitive (such as Staphylococcaus sp., 
Escherichia coli, Pseudomonas aeruginosa, and Bacillus sp) through conjugation or 
transduction gene transfer. Like the development of antibiotic resistance, human activities 
can create environments of high selection for metals and lead to metal resistance (Ji & Silver, 
1995). However, there is a contradiction in literature whether there is significant microbial 
resistance to silver in environments where silver is routinely used; such as, burns units in 
hospitals, silver-coated catheters and dental settings (amalgams contain 35 % silver).  
1.5. Innovative technologies 
Nanotechnology 
Science is faced with a challenge of inventing rapid, specific, portable and sensitive water 
purification technologies. Nanotechnology has the potential to produce materials that can be 
used for small-scale or point-of-use systems, which do not need a connected central 
infrastructure and could be used in emergency responses following disasters. 
Nanotechnology is the study and application of nanomaterials. It has the potential to produce 
water treatment systems that efficiently disinfect water while producing fewer pollutants than 
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traditional methods, and may require less labour, capital, land and energy. A nanomaterial is 
defined as a naturally occurring or artificially synthesised substance composed of particles, 
either in unbound state, aggregated or agglomerated, with a size distribution of one or more 
external dimensions ranging from 1 nm to 100 nm (Sahoo et al., 2009; Rosarin & Mirunalini, 
2011). Nanomaterials are fabricated by either bottom-up or top-down approaches as 
demonstrated in Figure 1.2 (Sahoo et al., 2009; Rosarin & Mirunalini, 2011). 
 
Figure 1.1: Illustration of top-down approach vs the bottom-up approach in the synthesis of nanoparticles.  
 
The top-down approach involves the breakdown of a bulk material into the nanoscale size 
without changing the elemental composition of the bulk material, an example may be laser 
ablation (Sahoo et al., 2009; Rosarin & Mirunalini, 2011). While the bottom-up approach 
fabricates nanoparticles by collecting, consolidating and fusing individual atoms and 
molecules to nanosized particles, an example could be chemical reduction (Rosarin & 
Mirunalini, 2011). The bottom-up approach has the potential to engineer homogenous 
nanostructures with less defects and controlled size distribution (Rosarin & Mirunalini, 
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2011). Nanoparticles can either occur naturally or be artificially synthesised (chemical 
reduction). These nano structures have an increased surface area to volume ratio that results 
in enhanced quantum mechanical effects (Thembela et al., 2006; Sahoo et al., 2009). 
Decreasing bulk material size to the nanoscale has resulted in enhanced optical, electrical, 
catalytic and toxic properties of that material (Thembela et al., 2006, Rai et al., 2009; Sahoo 
et al., 2009; Rosarin & Mirunalini, 2011).  
1.6. Silver nanoparticles  
1.6.1. Synthesis of silver nanoparticles 
The bottom-up approach synthesis of silver nanoparticles involves the reduction of ionic 
silver to elemental silver and then these silver atoms self-assemble to form particles between 
1 nm and 100 nm. There are several methods to prepare silver nanoparticles such as chemical 
reduction of silver ions in aqueous solutions with or without surfactants, electrochemical 
reduction, heat evaporation, and thermal decomposition in organic solvents, polyol process, 
photoreduction in reverse micelles, biological, radiochemical and chemical reduction (Sahoo 
et al., 2009). The chemical reduction method has been predominantly studied because it has 
the potential to produce nanoparticles of controlled size, shape and dispersion cheaply, and in 
a short period of time (Sahoo et al., 2009). The synthesis of silver nanoparticles by wet 
chemical method initially involves the dissociation of silver nitrate (AgNO3) into a silver ion 
(Ag
+
) and a negative nitrate ion (NO
3-
). Then in order to convert the silver ions into solid 
silver, Ag
+ 
has to be reduced by receiving an electron from a donor (Cao, 2004; Chou et al., 
2005). The equation below illustrates the reduction of the silver ions by addition of an 
electron. Subsequently silver atoms self-assemble and continue growing until the equilibrium 
between the final nanoparticles and the Ag
+
 of the solution is reached (Chou et al., 2005).   
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Optimising the reaction parameters such as, pH, temperature, amount of reducing agent and 
the presence of a stabilising agent is predicted to control the particle size, shape and 
dispersion. 
1.6.1.1. Effect of stabilising agent in the synthesis of silver nanoparticles 
A stabilising agent is a substrate that ideally prevents particle agglomeration. Stabilising 
agents form a protective shell that coats the nanoparticle and this layer increases the zeta 
potential therefore prevents nanoparticle agglomeration (Irwin et al., 2010). Stabilising 
agents include surfactants, polymers or ions that are responsible for increasing the zeta 
potential between particles therefore preventing agglomeration, hence controlling the particle 
size and dispersion in a colloidal system (Sahoo et al., 2009). The polymer (stabilising agent) 
attaches to the particle at one end therefore the polymer looks like tentacles on the particle. 
The alkaline pH and the presence of citrate as a dispersing agent has promoted the formation 
of mono-dispersed spherical silver nanoparticles (Qin et al., 2010). Likewise the use of 
polymer polyvinyl-pyrrolidone (PVP) as a stabilising agent has produced small particles with 
a uniform size distribution (Irwin et al., 2010). PVP is one of the known polymers that have 
high affinity for silver metal. This hydrophobic polymer covalently links to the silver metal 
by its pyridyl groups. The polymer binds to the AgNPs and forms a micelle around the 
nanoparticles. PVP is partially charged therefore causing inter-particle repulsion. Polymer 
molecules require a good solvent to perform at their utmost capability. If the solvent permits 
the stabilising agent to stretch away from the particle then the solvent is effective, whereas if 
the solvent makes the stabilising agent collapse on the surface of the particle then the solvent 
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is poor. These polymer molecules collapse when the nanoparticles are suspended in a poor 
solvent such as the acidic pH of the ascorbic acid based synthesis.  
1.6.1.2. The effect of temperature on the synthesis of silver nanoparticles  
Sahoo et al., (2009) synthesised AgNPs using sugars and found that increasing the 
temperature from 30 °C to 60 °C increases the nanoparticle size. The increase in temperature 
is directly proportional to the reaction rate and may cause agglomeration of the particles since 
the time will not be conducive to allow coating of the Ag
+
 by the stabilisers (Jiang et al., 
2011). Temperatures below 30 ⁰C tended to produce spherical particles smaller than 30 nm in 
size whereas temperatures between 30 ⁰C–60 ⁰C favoured the formation of triangular shaped 
nanoparticles between 40 nm and 100 nm in size (Jiang et al., 2011). Heating a solution with 
reduced silver ions supplies the silver atoms with enough kinetic energy to penetrate the 
polymer layer, favouring particle agglomeration (Cao, 2004). Therefore heating can be used 
to produce larger particles but the method of heating is important. Microwave heating is 
preferred to a hot plate due to homogeneous heat transfer to the solution instead of the 
localised heating produced by a hot plate.  
1.6.1.3. Effect of pH on the synthesis of silver nanoparticles 
When a substance wich is either positively or negatively charged is exposed to an electrolyte 
either the OH
-
 or H
+ 
adheres to its surface through the electrostatic interaction, therefore 
altering the surface charge. Point of Zero Charge (pzc) is a surface characteristic of a material 
and it is defined as the pH at which the surface of a material has a net neutral or zero charge. 
The point of zero charge of silver is estimated to be at pH 5.5 (Overbreek, 1952; Hunter, 
1987; Shaw, 1992). Qin et al., (2010) synthesised silver nanoparticles, where silver nitrate 
was reduced by ascorbic acid at different pH’s and demonstrated that increasing the pH from 
6 to 10.5 could alter the particle size from 73 nm to 31 nm. The alkaline pH and the presence 
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of a citrate as a dispersing agent promoted the formation of mono-dispersed spherical silver 
nanoparticles (Qin et al., 2010).  Sahoo et al., (2009) also agrees that alkaline pH (8.5-9.0) 
yielded smaller mono-dispersed nanoparticles at a faster rate than the acidic pH.  
1.6.1.4. Synthesis of silver nanoparticles with different shapes 
Several studies have predicted that silver nanoparticles with different shapes have diverse 
affects on the bacteria (Lkhagvajav et al., 2011; Morones et al., 2005; Dibrov et al., 2002; 
Goering et al., 2007). Jiang et al., (2011) exposed silver nanoparticle spheres to light and 
produced different shaped nanoparticles. Different shapes were formed at different 
maturation stages; for example spherical discs are immediately formed whereas triangle 
platelets form as the reaction progressed at elevated temperatures of about 40 ⁰ C and after 48 
hours of exposure the suspensions were a three-dimensional icosahedral structure (Jiang et 
al., 2011).  
1.6.2. Mode of action of silver nanoparticles 
The large surface area exposed in silver nanoparticles increases their interaction with the 
microorganisms therefore enhances the antimicrobial effect compared to other bulk silver ion 
counterparts (Morones et al., 2005; Sondia & Salopek-Sondib, 2004; Rai et al., 2009; Rosarin 
& Mirunalini, 2011; Furno et al., 2004; Lok et al., 2006). Silver nanoparticles have shown 
the ability to penetrate biofilms and have cidal effects even to virulent biofilm communities 
(Furno et al., 2004). The bactericidal effect of silver nanoparticles is not very well understood 
(Lkhagvajav et al., 2011; Dibrov et al., 2002). It is predicted to disrupt cellular metabolism, 
the electron transfer system, the transportation of substrate in the microbial cell membrane 
and suppresses respiration therefore hindering cellular development and replication and 
ultimately causing cell death (Fox & Modak, 1974; Sondia & Salopek-Sondib, 2004; Dibrov 
et al., 2002) [Figure 1.3].  
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Figure 1.2: The predicted silver nanoparticles mode of action in a bacterial cell. 
 
 
The nanoparticles react with cell membrane components and the constituents of the solution 
they are suspended in and get oxidised to produce silver ions. Silver ions interact with 
multiple cellular compartments; including protein, nucleic acids, ribosomes, cell membrane 
and the cell wall, in that way they could evade the emergence of microbial resistance 
(Morones et al., 2005; Sambhy et al., 2006; Parka et al., 2009; Rosarin & Mirunalini, 2011; 
Furno et al., 2004).  Silver ions directly inhibit the production of antioxidants leading to 
elevated reactive oxygen species (ROS) concentrations (Choi & Hu, 2008), which may cause 
nucleic acid and protein oxidation, activating apoptosis (Sondia & Salopek-Sondib, 2004; 
Dibrov et al., 2002; Parka et al., 2009; Rosarin & Mirunalini, 2011). Silver or silver ions bind 
to the sulfhydryl (SH-) groups of some enzymes therefore inhibiting their enzymatic activity 
(Lkhagvajav et al., 2011; Dibrov et al., 2002). Dibrov et al., (2002) revealed that 
submicromolar concentration of silver ions (Ag
+
) targets the sodium translocating NADH: 
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ubiquinone oxidoreductase therefore inhibiting energy-dependent sodium ions (Na
+
) transport 
in membrane vesicles of Vibrio cholerae. Low micromolar concentrations of Ag
+
 causes 
proton (H
+
)  leakage therefore collapsing the proton motive force, respiration-generated 
membrane electric potential and pH gradient across the mitochondrial membrane, therefore 
disrupting the  bacterial metabolism (Dibrov et al., 2002). This causes loss of energy which 
may result in cell death. Literature has confirmed that AgNPs have cidal effects against a 
range of microorganisms including Escherichia coli, Staphylococcus aureus, Candida 
albicans, Bacillus subtilis, Salmonella typhimurium, Pseudomonas aeruginosa, Vibrio 
cholerae and Klebsiella pneumoniae (Dibrov et al., 2002; Lkhagvajav et al., 2011).  
The mode of entry of the nanoparticles into a bacterial cell has not yet been identified, but 
silver nanoparticles have been found inside the cells. Lkhagvajav et al., (2011) suggested that 
the bacteriocidal effect is dependent on the ability of the nanoparticle to bind to the 
microorganisms and the high surface area available for interaction. Particles smaller than 40 
nm have an increased surface area available for the interaction which is directly proportional 
to the greater bactericidal effect they have, as compared to particles larger  than 40 nm 
(Lkhagvajav et al., 2011). The silver nanoparticles between 1 and 10 nm showed direct 
interaction with the bacteria cell wall. These small particles have the ability to react with, and 
penetrate, the cell membrane because of their higher surface to volume ratio. Particles smaller 
than 5 nm have enhanced electronic effects that can change the local electronic structure of 
the bacterial surface (Pal et al., 2007). Morones et al., 2005 predicted that smaller particles 
can penetrate the cell membrane more easily than large nanoparticles. Some researchers have 
implied that different particle shapes such as, octahedral, multiple-twinned icosahedral, 
decahedral, tubes, spheres and triangle shaped nanoparticles may have diverse effects on the 
bacteria (Pal et al., 2007; Jiang et al., 2011).  
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1.6.3. Application and developments of silver nanoparticles based products 
There are over 100 silver nanoparticles based products in the market. Sweet and Singleton 
(2011) reviewed commercially available products that contain silver nanoparticles such as 
textiles, medical devices, food preservatives, water purifying systems and surface coatings. 
There is a portable drinking water purifying system that is designed by incorporating silver 
nanoparticles into a blotter paper (Dankovich & Gray, 2011; You et al., 2011). Nanobiocides 
such as metal nanoparticles have been successfully incorporated into nanocomposites and 
their slow release into the water to directly kill microbes yet maintain an acceptable human 
silver dose of 100 mg/L in water was sustained (Rai et al., 2009). Table 1.1 lists some of the 
silver nanoparticles based products currently on the market. 
Table 1.1: Antimicrobial uses of AgNPs.  
AgNP-containing products  Reference 
Textiles and clothing  Leung & Ko, (2011) 
Medical implants  Furkert et al., (2011); Lu et al., (2011) 
Surface coating (work surfaces, kitchens) Galeano et al., (2003); Sreekumari et al., 2005 
Food preservation  Del Nobile et al., (2004);Fernandez et al., (2010) 
Purification of drinking water  Dankovich & Gray, 2011 
Wastewater treatment  Musee et al., (2011) 
Household items (e.g., washing machines, deodorants) Kim et al., (2010) 
 
Silver nanoparticles immobilised in silica spheres were found to be an efficient catalyst in the 
reduction of dye by sodium borohydride. The increase in the amount of silver nanoparticles 
reduced the reaction time by two thirds (Jiang et al., 2004). In addition, many nanoparticles 
function as catalysts as their high energy surfaces are more reactive than the surfaces of bulk 
materials due to the large surface curvature. Smaller nanoparticles exhibit quantum 
confinement, which occurs when the physical dimensions of the nanoparticles are smaller 
than the mean free path of the electrons. 
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1.6.4. Toxicity of silver nanoparticles 
As expected for every rising technology there are issues that are in question regarding 
nanotechnology such as: toxicity, ecological impact and the global economics (Rosarin & 
Mirunalini, 2011). Hence the implementation of these developments is slow because 
nanotechnology is under advocacy and regulation. Prolonged contact with or ingestion of 
silver compounds is known to cause Argyria, which is a phenomenon where silver deposits 
underneath the skin and results in gray to gray-black staining of the skin and mucous 
membranes (Rai et. al., 2009; Rosarin & Mirunalini, 2011). The small size, larger surface to 
area ratio, high mobility and reactivity of AgNPs poses more harm to human beings (Borm & 
Kreyling, 2004) and the ecosystem (DuránI et al., 2010). The Guidelines for drinking-water 
quality (1996) limits the amount of silver exposure to 0.1 mg/L, a concentration that gives a 
total dose over 70 years of 10 g, which can be tolerated without risk to health. Hussain et al., 
(2005) evaluated the acute toxicity of 15 or 100 nm AgNPs invitro using a rat liver derived 
cell line (BRL 3A). A dose-dependent cytotoxicity, impaired mitochondrial function and cell 
shrinkage were observed after 24 hours. Cytotoxicity increased with a decrease in particle 
size. Burd et al., (2007) also reported a dose dependent cytotoxicity of silver ion or metallic 
nanocrystalline silver on monolayer cell culture, a tissue explant culture model and a mouse 
expurgated wound model. Nanoparticles can be inhaled, (Oberdorster et al., 2001), orally 
ingested (Jani et al., 1990) and absorbed through skin contact (Kreilgaard et al., 2002); post 
uptake the nanoparticles can spread to different body tissues. Takenaka et al., (2001) reported 
detection of AgNPs in the lung, liver, kidney, spleen, brain, heart, and blood of rats post 
inhalation of 4-10 nm ultrafine particles. However, with so many silver nanoparticle-based 
products in the market there have been no toxicity incidences reported (DuránI et al., 2010). 
Small quantities of silver nanoparticles have been administered in human cells and have been 
shown to inactivate HIV and prevent the propagation of the virus (Rosarin & Mirunalini, 
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2011). Braydich-Stolle et al., (2005) investigated the effect of silver nanoparticles on a mouse 
spermatogonial stem cell line and discovered that the nanoparticles disrupted the cell 
morphology, mitochondrial function and also caused membrane leakage therefore interfering 
with cellular metabolism. The ingestion and constant contact with silver nanoparticles can 
affect the normal flora and be cidal to the essential bacteria that produce vitamin K in the gut.  
1.6.5. Characterization techniques used to analyse silver nanoparticles 
This section reviews the characterisation techniques used to determine the structure and 
properties of silver nanoparticles  
1.6.5.1. UV-visible spectroscopy 
UV-vis spectroscopy is a useful tool in studying electronic transition of species that absorb at 
near infrared through the visible to the UV region of electromagnetic spectrum with transition 
energy in the approximate range between10
2 
and 10
3
 kJ mol
-1
. These species absorb this light 
then undergo an electron transition whereby a valence electron gets excited from ground state 
to the excited state (i.e. from lower energy to higher energy). Optical excitation of electrons 
across the band gap is strongly allowed, producing an abrupt increase in absorption at the 
wavelength corresponding to the band gap energy. The energy required to promote an 
electron from valence band to the conduction band for most metals is in the same energy 
region, thus UV-vis spectroscopy is a powerful technique to study the interband electronic 
transition of these metals. Ultraviolet-visible spectroscopy (UV-vis) is used to determine the 
optical properties of a solution. Light is sent through the sample and the amount of light 
absorption and scattering patterns are measured. The technique concurrently examines the 
colour and the current of a material then measures the wavelength at which the maximum 
absorption (λmax) band occurs. Elemental silver absorbs energy in the form of photons 
between 350 nm and 450 nm whereas ionic silver does not absorb at this wavelength 
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(Vigneshwaran et al., 2006). The degree of light absorption and scattering is dependent on 
the size of the AgNPs. Evanoff and Chumanov, (2004) stated that AgNPs with UV-vis 
spectra that depict a dipole resonant mode maximally absorb light and none or minute 
amounts are transmitted, scattered or reflected. Literature seconds this conclusion since the 
extinction spectra and the absorbance of small nanoparticles is similar whereas the extinction 
spectra of larger nanoparticles have higher amplitude than the absorption spectra of the same 
nanoparticles (Kumbhar et al., 2005). Absorption peaks occurring at lower wavelengths 
imply a blue-shifted absorption edge resulting from quantum confinement of the excitons 
present in the sample. The excitons present in the sample cause a more discrete energy 
spectrum of the individual nanoparticles. If no visible absorption is seen in the visible region, 
the system can be said to be a non-linear optical (NLO) material. Kumbhar et al., (2005) 
investigated optical properties of different sized AgNPs and the extinction spectra of those 
AgNPs are represented in Figure 1.6. The AgNPs with diameters ranging between 1 and 60 
nm have one plasmon peak belonging to a dipolar mode, because particles smaller than 60 
nm maximally absorbed light with minimum light scattering. Evanoff and Chumanov (2004), 
stated that the extinction spectrum of particles smaller than 60 nm is mainly contributed by 
absorbed light. The increase in particle size causes red shift in the dipole mode peak from 400 
nm to 600 nm. In addition to the dipole mode, particles larger than 60 nm have a shoulder at 
about 450 nm called octupole mode and as the particle size increases above 100 nm the 
extinction spectra shows a quadropole mode around 550 nm [Fig 1.4]. The absorption 
spectrum of AgNPs broadens as the nanoparticle size distribution increases therefore 
contributing to a wider full width at half-maximum (FWHM). 
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Figure 1.3 : UV-Vis spectra of different sized AgNPs ranging from 10 nm (bottom blue line) to 215 nm (top 
green line) dispersed in water. (Adapted from Kumbhar et al., 2005) 
 
1.6.5.2. Transmission electron microscopy and Energy Dispersive Spectroscopy  
Transmission electron microscopy (TEM) measures the interaction of transmitted electrons as 
they pass through an ultra-thin specimen. The principle involves projection of an electron 
beam that is primarily focused by a series of magnetic lenses into the specimen, then the 
electrons will be absorbed and scattered as they interact with the specimen. Subsequently the 
transmitted electrons will be focused by the objective lenses then detected by the detector 
which creates an image visualised by the CCD cameras (Lambert & Mulvey, 1996). Then the 
transmitted electrons give an image with useful information about the morphology of a 
material. The particle to particle interaction will be conveyed by the dispersion or 
agglomeration of the particles that make up the specimen. The technique analyses the crystal 
structure, particle shape and size of the silver nanoparticles (Chen et al., 2010; Rosarin & 
Mirunalini, 2011, Zhang et al., 2003; Chen et al., 2010; Rai et al., 2009). 
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1.7. Proposal 
1.7.1. Problem Statement 
The world is faced with the burden of emerging waterborne pathogens, which are more 
virulent and resistant to conventional disinfection methods. This necessitates the development 
of broad-spectrum antimicrobial agents that are effective against emerging pathogens while 
delaying the emergence of resistance. With the increased environmental and economic 
concern these new disinfection methods should be cheap and not emit greenhouse gases. 
These “point of use” disinfection techniques should not require specialised infrastructure or 
trained personnel, as most of the areas affected by waterborne disease outbreaks are in the 
rural areas where there is a lack of proper municipal water treatment systems. 
Innovative techniques such as a nanocomposite containing filtering systems have been 
developed. Silver nanoparticles and their  nanocomposites have a potential to be broad-
spectrum antimicrobial agents as they have cidal effects against a wide range of pathogenic 
microorganisms and a wide mode of action (deactivate proteins, retards DNA replication, 
formation of reactive oxygen species and ion imbalance) thus can prolong the emergence of 
resistance.   
The literature has predicts that small AgNPs are more toxic and there has been research in 
trying to optimise the synthesis of such nanoparticles. However, the ideal nanoparticle 
remains elusive. This study serves to bridge the gap through changing the parameters asserted 
by literature to synthesise silver nanoparticles with high cidal effects against a wide range of 
bacterial species. Although the antimicrobial effect of silver nanoparticles has been studied, a 
comparison of their superiority to the conventional disinfection methods or to antibiotics has 
not been conducted. In the present study, the synthesised silver nanoparticles will be tested on 
a range of bacteria. To date the binding, localisation and accumulation of AgNPs is not clear 
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so transmission electron microscopy (TEM) will be employed to visualise the accumulation 
of AgNPs.  
1.7.2. Aim 
The present study is aimed at investigating the efficiency of silver nanoparticles as an 
antibacterial agent.  
1.7.3. Objectives of study 
The present study aims to investigate the effects of silver nanoparticles on several bacterial 
strains with the specific objectives: 
 To optimise the synthesis of small stable silver nanoparticles  
 To produce homogeneously shaped and dispersed AgNPs colloids  
 To compare bacterial growth retardation in response to AgNPs  
 To establish the minimum inhibitory concentration of the AgNPs 
 To compare the cidal efficacy of silver nanoparticles over silver compounds 
 To investigate the entry and mode of action of silver nanoparticles 
 To investigate the binding and accumulation of AgNPs on the bacteria 
1.7.4. Primary Research Questions 
 What reaction parameters are responsible for a certain shape or size of AgNPs? 
 What is the minimum cidal or static concentration of silver nanoparticles?  
 Are AgNPs more toxic that Ag+? 
 Do silver nanoparticles enter the microorganism? 
 What is the mode of entry and action of silver nanoparticles in a bacterial cell? 
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1.7.5. Hypotheses 
Low temperatures, alkaline pH and abundant reducing and stabilising agents produce small 
particles. Silver nanoparticles have enhanced bactericidal effect as compared to silver ions. 
The mode of action of AgNPs is distinct to that of Ag
+
. 
1.7.6. Model organisms  
A model organism is defined as a non-human species sharing a common ancestor, or with 
similar metabolic pathway, developmental pathways and genetic makeup with the organisms 
in question. The biological phenomena of model organisms have been extensively studied 
and they are safe to handle in a biosafety level 1 laboratory. They are used when it is 
unfeasible or unethical to work with pathogenic strains. To evaluate the hypothesis of the 
current study the model bacterial strains that were used are Escherichia coli 1699, 
Staphylococcus epidermidis, Bacillus cereus, Mycobacterium smegmatis and Cupriavidus 
metallidurans (CH34).  
B. cereus is physiologically and biochemically similar to virulant spore-forming bacteria such 
as B. thuringiensis and B. anthracis. Therefore B. cereus will aid in investigating the 
efficiency of silver nanoparticles in eradicating spore-forming bacteria. S. epidermidis will be 
used to examine the efficiency of silver nanoparticles in inhibiting the growth of biofilm-
forming bacteria.  
Mycobacterium smegmatis is structurally and genetically similar to Mycobacteriaceae spp 
Often Mycobacteriaceae are associated with resistance since they have longer incubation 
periods and possess a cell wall that is highly impermeable to antimicrobial agents. Rodgers et 
al., (1999) stated that that Mycobacterium can resist heavy metals therefore M. smegmatis, 
will be used to test this hypothesis and the ability of silver nanoparticles to enter the 
mycobacterium distinct cell wall. 
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E. coli is an indicator of faecal contamination, where the presence of 100 cfu/ml of E. coli in 
a water sample poses a hazard of the presence of pathogens such as Vibrio cholerea, 
Salmonella typhi and Leptospira spp. The sensitivity of the indicator organism may reflect 
the efficiency of the antimicrobial agent in eradicating pathogens. The E. coli 1699 strain 
used in this study has been genetically engineered to be resistant to over 50 antibiotics. 
Cupriavidus metallidurans (CH34) is not pathogenic to humans but it is known to adapt in 
areas contaminated with heavy metal stress such as Ag (I), Zn(II), Cd(II), Co(II), Ni(II), 
Cu(II), CrO, Hg(II) and Pb(II) amongst others (Mergeay et al., 2003; Rojas et al., 2011). It is 
a gram-negative, facultative anaerobic chemolithoautotroph. This extremophile is also 
involved in heavy metal remediation and sensing. The predicted mode of action of AgNPs 
includes the oxidation of AgNPs therefore, release silver ions (Ag
+
) which then interact with 
the microorganism. In trying to examine this prediction a bacterial strain that is known to 
resist Ag
+
 by reducing them into Ag, C. metallidurans, will be exposed to AgNPs. C. 
metallidurans will be used as a model organism to investigate the mode of action of silver 
nanoparticles and degree of emergence of efflux if the silver nanoparticles accumulate.  
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Chapter 2 
Methodology  
This chapter details the research design used in this study such as synthesis and 
characterization of silver nanoparticles (AgNPs), and it further describes methods that were 
chosen in the investigation of the antibacterial properties of these nanoparticles. Additionally 
the chapter portrays the motive for the choice of methods and techniques used in the study. 
Figure 2.1 describes the experimental approach followed in pursuit of the objectives of this 
study. 
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Figure 2.1: Schematic representation of the experimental approach.  
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2.1. Materials 
2.1.1. Chemicals and Bacterial strains used in this study 
2.1.1.1. Bacterial strains used in the study  
The E. coli (1699) and M. smegmatis were obtained in an agreement with a collaborator, Dr. 
Victoria Knight-Connoni, Cubist Pharmaceuticals. The C. metallidurans (ATCC 43123 / 
DSMZ 2839) was a DSMZ acquisition. The S. epidermidis and B. cereus (ATCC10702I) 
were obtained at IMBM, UWC, South Africa. 
2.1.1.2. Chemicals used in the study 
Silver nitrate (99.80 %), sodium borohydride (99.90 %), ascorbic acid (99.00 %), sodium 
chloride (99.80 %) and sodium hydroxide (99.9 %) were purchased from Kimix Chemicals. 
Nitric acid (65.00 %), tryptone powder, casein peptone (99.90 %) and Peptone powder (99.90 
%) were purchased from Merck Chemicals. Yeast extract, citric acid, D-(+)-glucose (99.5 %) 
Hydrochloric acid (37.00 %), Polyvinylpyrrolidone, ethanol, sodium chloride, osmium 
tetroxide, glutaraldehyde (25 %), resin, acetone and Tryptic soy broth were purchased from 
Sigma Aldrich. Casamino acid was purchased from Becton, Dickson and Company.  
2.1.2. Sample Storage  
Silver nanoparticle solutions were stored in sealed polyethylene containers to avoid any 
moisture uptake. The bacterial glycerol stocks were stored at -80 ⁰C. Solutions were prepared 
fresh and were stored at 4 °C before analyses or antibacterial tests. 
2.2 Silver nanoparticles synthesis 
The theory of silver nanoparticles synthesis involves the reduction of silver ion to zero valent 
silver atoms, then these silver atoms self assemble into nanostructures (1 to 100 nm). Silver 
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nitrate (AgNO3) was used as the silver precursor. The silver ions (Ag
+
) were reduced by 
chemical reduction using ascorbic acid or sodium borohydride as reducing agents. The silver 
nanoparticles were synthesised using two methods: section 2.2.1 describes the first method 
which used ascorbic acid as a reducing agent and section 2.2.2 describes the second method 
which used sodium borohydride as a reducing agent. Literature suggests that controlling the 
reaction parameters can influence the quality of the silver nanoparticles. In each method, the 
reaction parameters such as the amount of reducing agent, the amount of stabilising agent, the 
temperature and the pH were individually varied to investigate the influence that these 
parameters have on the size and shape of the silver nanoparticles. 
2.2.1. AgNP synthesis through the reduction of silver ions by ascorbic acid 
The silver nanoparticles were synthesised according to the recipe described by Qin et al., 
(2010). The syntheses of silver nanoparticles were carried out by using ascorbic acid as 
reducing agent. Citric acid or Polyvinylpyrrolidone (PVP) was used as stabilising agents. 
2.2.1.1. Investigating the effect of reducing agent  
The effect of the reducing agent on the silver nanoparticles size was investigated by varying 
the concentration of ascorbic acid used to reduce the silver ions. Other reaction parameters 
such as the temperature, the pH and the amount of stabilising agent (citric acid) were kept 
constant. The synthesis was controlled at 30 ⁰C, pH 10.5 and 2.781 x 10-3 M citric acid. Table 
2.1 summarises the reaction conditions and molar ratio of citric acid/Ag and that of ascorbic 
acid/Ag. 
Table 2.1: Investigating the effect of ascorbic acid. 
 
Sample ID Ag (µg/mL) Ascorbic acid: Ag Citric acid: Ag Temperature (⁰C) pH 
AA1 100 1 3 30 10.5 
AA2 100 3 3 30 10.5 
AA3 100 4 3 30 10.5 
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The initial concentration of ascorbic acid used to achieve the ascorbic acid/Ag molar ratio of 
1, 3 and 4 were 4.635 x 10
-4
 M, 1.39 x 10
-3
 M and 1.85 x 10
-3
 M ascorbic acid respectively. 
An aqueous solution (10 mL) containing ascorbic acid and 2.781 x 10
-3
 M citric acid was 
adjusted to pH 10.5 by adding 0.1 M NaOH solution. Then the solution was left shaking in a 
30 ⁰C water-bath for 30 minutes. Subsequently 100 µL of 0.1 M AgNO3 was added drop-
wise and the mixture was allowed to shake for 15 minutes after adding silver.  The resulting 
samples, labelled AA1, AA2 and AA3 for the ascorbic acid/Ag molar ratio of 1, 3 and 4 
respectively, were analysed by UV-vis spectroscopy.  
2.2.1.2. Investigating the effect of stabilising agent  
An efficient stabilising agent produces stable and a small silver nanoparticle size with a 
narrow particle size distribution. In an attempt to select an efficient stabilising agent, the 
synthesis of silver nanoparticles was carried out in the presence of either citric acid or 
Polyvinylpyrrolidone (PVP).  
2.2.1.2.1. Investigating the effect of citric acid  
The effect of the stabilising agent on silver nanoparticles was investigated by varying the 
concentration of citric acid. Other reaction parameters such as the temperature, the pH and 
the amount of ascorbic acid used were kept constant. The synthesis was controlled at 30 ⁰C, 
pH 10.5 and 4.635 x 10
-4
 M ascorbic acid. Table 2.2 summarises the reaction conditions and 
molar ratio of citric acid/Ag and that of ascorbic acid/Ag of samples AA4, AA5 and AA6. 
Table 2.2: Investigating the effect of citric acid. 
 
The citric acid/Ag molar ratio varied at 0, 3 and 10 for sample AA4, AA5 and AA6. The 
initial concentration of citric acid used to achieve the citric acid/Ag molar ratio of 0, 3 and 10 
Sample ID Ag (µg/mL) Ascorbic acid: Ag Citric acid: Ag Temperature (⁰C) pH 
AA4 100 1 0 30 10.5 
AA5 100 1 3 30 10.5 
AA6 100 1 10 30 10.5 
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were 0 M, 2.781 x 10
-3
 M and 9.27 x 10
-3
 M citric acid respectively. An aqueous solution (10 
mL) containing 4.635 x 10
-4
 M ascorbic acid and citric acid was adjusted to pH 10.5 by 
adding 0.1 M NaOH solution. Then the solution was left shaking in a 30 ⁰C water-bath for 30 
minutes. Subsequently 100 µL of 0.1 M AgNO3 was added drop-wise and the mixture was 
allowed to shake for 15 minutes after adding silver.  The resulting samples were analysed by 
UV-vis spectroscopy. The resulting samples, labelled AA4, AA5 and AA6 for the citric 
acid/Ag molar ratio of 0, 3 and 10 respectively, were analysed by UV-vis spectroscopy.  
2.2.1.2.2. Investigating the effect of Polyvinylpyrrolidone  
The effect of the stabilising agent on the silver nanoparticle size was investigated by varying 
the concentration of PVP used in the synthesis of silver nanoparticles. Other reaction 
parameters such as the temperature, the pH and the amount of ascorbic acid used were kept 
constant. The synthesis was controlled at 30 ⁰C, pH 10.5 and 4.635 x 10-4 M ascorbic acid. 
The PVP/Ag molar ratio was varied at 0, 3 and 10 for sample AA4, AA7 and AA8. Table 2.3 
summarises the reaction conditions and molar ratio of citric acid/Ag and that of ascorbic 
acid/Ag used in the synthesis of samples AA4, AA7 and AA8. 
Table 2.3: Investigating the effect of Polyvinylpyrrolidone. 
 
The initial concentration of PVP used to achieve the PVP/Ag molar ratio of 0, 3 and 10 were 
0 M, 2.781 x 10
-2
 M and 9.27 x 10
-2
 M PVP respectively. A 10 mL of 4.635 x 10
-4
 M ascorbic 
acid aqueous solution was adjusted to pH 10.5 by adding 0.1 M NaOH solution. Then the 
solution was left shaking in a 30 ⁰C water-bath for 30 minutes. Subsequently 100 µL aqueous 
solution containing 0.1 M AgNO3 and PVP was added drop-wise to the shaking ascorbic acid 
solution and the mixture was allowed shake for 15 minutes after adding silver. The resulting 
Sample ID Ag (µg/mL) Ascorbic acid: Ag  PVP Temperature (⁰C) pH 
AA4 100 1 0 30 10.5 
AA7 100 1 3 30 10.5 
AA8 100 1 10 30 10.5 
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samples, labelled AA4, AA7 and AA8 for the PVP/Ag molar ratio of 1, 3 and 4 respectively, 
were analysed by UV-vis spectroscopy.  
2.2.1.3. Investigating the effect of temperature 
This set of experiments investigated the effect of temperature on the size of AgNPs. Silver 
nanoparticles were synthesised by chemical reduction with ascorbic acid and stabilised by 
citric acid at pH 10.5 at varying temperature of 25 ⁰C, 30 ⁰C or 50 ⁰C for sample AA9, AA10 
and AA11 respectively. Other reaction parameters such as the pH, the amount of ascorbic 
acid and the amount of citric acid were kept constant. The synthesis was controlled at pH 
10.5, 2.781 x 10
-3
 M citric acid and 4.635 x 10
-4
 M ascorbic acid.  Table 2.4 summarises the 
reaction conditions and molar ratio of citric acid/Ag and that of ascorbic acid/Ag used in the 
synthesis of samples AA9, AA10 and AA11. 
Table 2.4: Investigating the effect of temperature. 
 
An aqueous solution (10 mL) containing 4.635 x 10
-4
 M ascorbic acid and 2.781 x 10
-3
 M 
citric acid was adjusted to pH 10.5 by adding 0.1 M NaOH solution. Then the solution was 
left shaking for 30 minutes in a 25 ⁰C, 30 ⁰C or 50 ⁰C water-bath respectively. Subsequently 
100 µL of 0.1 M AgNO3 was added drop-wise and the mixture was allowed to shake for 15 
minutes after adding silver.  The resulting samples, labelled AA9, AA10 and AA11 for 25⁰C, 
30 ⁰C and 50 ⁰C respectively, were analysed by UV-vis spectroscopy.  
2.2.1.4. Investigating the effect of pH 
This set of experiments investigated the influence of pH on the size of AgNPs. Silver 
nanoparticles were synthesised by chemical reduction with ascorbic acid and stabilised by 
Sample ID Ag (µg/mL) Ascorbic acid: Ag Citric acid: Ag Temperature (⁰C) pH 
AA9 100 1 3 25 10.5 
AA10 100 1 3 30 10.5 
AA11 100 1 3 50 10.5 
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citric acid at 30 ⁰C while varying the pH. Other reaction parameters such as the temperature, 
the amount of ascorbic acid and the amount of citric acid were kept constant. The synthesis 
was controlled at 30 ⁰C, 2.781 x 10-3 M citric acid and 4.635 x 10-4 M ascorbic acid. The pH 
was controlled at pH 5.5, 9 or 10.5 for sample AA12, AA13 and AA14 respectively. Table 
2.5 summarises the reaction conditions and molar ratio of citric acid/Ag and that of ascorbic 
acid/Ag used in the synthesis of samples AA12, AA13 and AA14. 
Table 2.5: Investigating the effect of pH. 
 
An aqueous solution (10 mL) containing 1.39 x 10
-3
 M ascorbic acid and 2.781 x 10
-3
 M 
citric acid was adjusted to pH 5.5, 9 or 10.5 respectively by adding 0.2 M citric acid or 0.1 M 
NaOH solution. Then the solution was left shaking in a 30 ⁰C water-bath for 30 minutes. 
Subsequently 100 µL of 0.1 M AgNO3 was added drop-wise and the mixture was allowed to 
shake for 15 minutes after adding silver. The resulting samples, labelled AA12, AA13 or 
AA14 for pH 5.5, 9 and 10.5 respectively, were analysed by UV-vis spectroscopy. 
2.2.2. AgNP synthesis through the reduction of silver ions by sodium 
borohydride 
The silver nanoparticles were synthesised according to the recipe described in Solomon et al 
(2007). The syntheses of silver nanoparticles were carried out by using sodium borohydride 
as reducing agent and citric acid or Polyvinylpyrrolidone (PVP) was used as stabilising 
agents.  
Sample ID Ag (µg/mL) Ascorbic acid: Ag Citric acid: Ag Temperature (⁰C) pH 
AA12 100 1 3 30 5.5 
AA13 100 1 3 30 9 
AA14 100 1 3 30 10.5 
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2.2.2.1. Investigating the effects of reducing agent 
This set of experiments investigated the effect of varying the amount of sodium borohydride 
on the size and shape of AgNPs. The temperature, the pH and the amount of PVP were kept 
constant. The synthesis was controlled at 0 ⁰C, pH 9.78 and 9.27x10-3 M PVP. Ag+ was 
reduced using sodium borohydride at NaBH4/Ag molar ratio of 3, 10 or 16 for sample BB1, 
BB2 and BB3 respectively. The initial concentration of sodium borohydride used to achieve 
the NaBH4/Ag molar ratio of 3, 10 and 16 were 4.635 x 10
-4
 M, 1.39 x 10
-3
 M and 1.85 x 10
-3
 
M sodium borohydride respectively. The solutions were prepared and chilled to ice 
temperature and the reaction was carried out on ice. Table 2.6 summarises the reaction 
conditions and molar ratio of PVP/Ag and that of NaBH4/Ag used in the synthesis of samples 
BB1, BB2 and BB3. 
Table 2.6: Investigating the effect of sodium borohydride. 
 
An aqueous solution (30 mL) containing 3.7x10
-3 
M, 1.23x10
-2
 M or 1.98×10
−2
 M NaBH4 for 
sample BB1, BB2 or BB3 respectively, was adjusted to pH 9.78 by adding 0.1 M NaOH. The 
solution was poured into an Erlenmeyer flask, and then the flask was placed in an ice bath on 
a stir plate. The solution was stirred and cooled for 20 minutes. Then 10 mL of aqueous 
3.8×10
−3
 M AgNO3 was added into the stirring NaBH4 solution at approximately 1 drop per 
second. Stirring was discontinued immediately after adding silver nitrate. Then 0.0148 g PVP 
was added into AgNPs solution and then the solution was stirred to dissolve the PVP. The 
resulting samples were analysed by UV-vis spectroscopy. 
 
Sample 
ID 
Silver (µg/mL) NaBH4:Ag PVP:Ag Temperature (⁰C) pH 
BB1 100 3 10 0 9.78 
BB2 100 10 10 0 9.78 
BB3 100 16 10 0 9.78 
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2.2.2.2. Investigating the effect of the stabilising agent  
2.2.2.2.1. Investigating the effect of citric acid 
This set of experiments investigated the effect of varying the amount of citric acid on the size 
and shape of AgNPs. The temperature, the pH and the amount of sodium borohydride were 
kept constant. The synthesis was controlled at 0 ⁰C, pH 9.78 and 1.98×10−2 M NaBH4. 
AgNPs was stabilised using citric acid at citric acid/Ag molar ratio of 0, 3 and 10. The initial 
concentration of citric acid used to achieve the citric acid/Ag molar ratio of 0, 3 or 10 were 0 
M, 2.781x10
-3
 M and 9.27x10
-3
 M citric acid respectively.  The solutions were prepared and 
chilled to ice temperature and the reaction was carried out on ice. Table 2.7 summarises the 
reaction conditions and molar ratio of citric acid/Ag and that of NaBH4/Ag used in the 
synthesis of samples BB4, BB5 and BB6. 
Table 2.7: Investigating the effect of citric acid. 
 
A 30 mL 1.98×10
−2
 M NaBH4 aqueous solution was adjusted to pH 9.78 by adding 0.1 M 
NaOH. The solution was poured into an Erlenmeyer flask, and then the flask was placed in an 
ice bath on a stir plate. The solution was stirred and cooled for 20 minutes. Then 10 mL of 
aqueous 3.8×10
−3
 M AgNO3 solution was added into the stirring NaBH4 solution at 
approximately 1 drop per second. Stirring was discontinued immediately after adding silver 
nitrate. Then 0 g, 23.2 mg or 7.79 mg citric acid was added into AgNPs solution sample BB4, 
BB5 and BB6 respectively. Subsequently the solution was stirred to dissolve the citric acid. 
The resulting samples were analysed by UV-vis spectroscopy. 
 
 
Sample 
ID 
Silver (µg/mL) NaBH4: Ag Citric acid: Ag Temperature (⁰C) pH 
BB4 100 16 0 0 9.78 
BB5 100 16 3 0 9.78 
BB6 100 16 10 0 9.78 
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2.2.2.2.2. Investigating the effect of Polyvinylpyrrolidone 
This set of experiments investigated the effect of varying the amount of Polyvinylpyrrolidone 
(PVP) on the size and shape of AgNPs. The temperature, the pH and the amount of sodium 
borohydride were kept constant. The synthesis was controlled at 0 ⁰C, pH 9.78 and 
1.98×10
−2
M NaBH4. AgNPs were stabilised using PVP at PVP/Ag molar ratio of 0, 3 and 10. 
The initial concentration of PVP used to achieve the PVP/Ag molar ratio of 0, 3 or 10 were 0 
M, 2.781x10
-3
 M and 9.27x10
-3
 M PVP respectively.  The solutions were prepared and 
chilled to ice temperature and the reaction was carried out on ice. Table 2.8 summarises the 
reaction conditions and molar ratio of PVP/Ag and that of NaBH4/Ag used in the synthesis of 
samples BB4, BB7 and BB8.  
Table 2. 8: Investigating the effect of PVP.  
 
The pH of 1.98×10
−2
 M NaBH4 aqueous solution (30 mL) was adjusted to pH 9.78 by adding 
0.1 M NaOH. The solution was poured into an Erlenmeyer flask, and then the flask was 
placed in an ice bath on a stir plate. The solution was stirred and cooled for 20 minutes. Then 
10 mL of aqueous 3.8×10
−3
 M AgNO3 solution was added into the stirring NaBH4 solution at 
approximately 1 drop per second. Stirring was discontinued immediately after adding silver 
nitrate. Then 0 g, 4.5 mg or 14.8 mg PVP was added into AgNPs solution in sample BB4, 
BB7 and BB8 respectively. Subsequently the solution was stirred to dissolve the PVP. The 
resulting samples were analysed by UV-vis spectroscopy. 
2.2.2.3. Investigating the effects of temperature 
This set of experiments investigated the effect of temperature on the size and shape of 
AgNPs. The pH and the amount of sodium borohydride and the amount of PVP were kept 
Sample 
ID 
Silver (µg/mL) NaBH4:Ag PVP:Ag Temperature (⁰C) pH 
BB4 100 16 0 0 9.78 
BB7 100 16 3 0 9.78 
BB8 100 16 10 0 9.78 
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constant. The synthesis was controlled at pH 9.78, 1.98×10
−2
 M NaBH4 and 9.27x10
-3
 M 
PVP. Table 2.9 summarises the reaction conditions and molar ratio of PVP/Ag and that of 
NaBH4/Ag used in the synthesis of samples BB9 and BB10.  
Table 2.9: Investigating the effect of temperature. 
 
In the preparation of sample BB10, the solutions were prepared and allowed to cool in ice for 
30 minutes prior to the synthesis and the synthesis was also carried out on ice [Fig 2.2 (A)]. 
In the preparation of sample BB11, the solutions were prepared at room temperature and the 
synthesis was carried out at 25°C, [Fig 2.2 (B)]. 
    
Figure 2.2: Setup for the experiment for AgNPs synthesised at different temperature. 
A) The synthesis carried out at 0 ⁰C. B) The synthesis carried out at 25 ⁰C.  
 
Preparation of BB9: The pH of 1.98×10
−2
 M NaBH4 aqueous solution (30 mL) was adjusted 
to pH 9.78 by adding 0.1 M NaOH. The solution was poured into an Erlenmeyer flask, and 
then the flask was placed in an ice bath on a stir plate. The solution was stirred and cooled for 
20 minutes. Then 10 mL of aqueous 3.8×10
−3
 M AgNO3 solution was added into the stirring 
NaBH4 solution at approximately 1 drop per second. Stirring was discontinued immediately 
after adding silver nitrate. The resulting samples were analysed by UV-vis spectroscopy. 
Preparation of BB10: The pH of 1.98×10
−2
 M NaBH4 aqueous solution (30 mL) was adjusted 
to pH 9.78 by adding 0.1 M NaOH. The solution was poured into an Erlenmeyer flask, and 
then the flask was placed on a stir plate at room temperature. The solution was stirred for 20 
Sample 
ID 
Silver (µg/mL) NaBH4: Ag PVP: Ag Temperature (⁰C) pH 
BB9 100 16 10 0 9.78 
BB10 100 16 10 25 9.78 
BB11 100 16 10 50 9.78 
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minutes. Then 10 mL of aqueous 3.8×10
−3
 M AgNO3 solution was added into the stirring 
NaBH4 solution at approximately 1 drop per second. Stirring was discontinued immediately 
after adding silver nitrate. Then 14.8 mg PVP was added into AgNPs solution and then the 
solution was stirred to dissolve the PVP. The resulting samples were analysed by UV-vis 
spectroscopy. 
2.2.2.4. Investigating the effects of pH 
This set of experiments investigated the effect of varying pH on the size and shape of AgNPs. 
The temperature, the amount of PVP and the amount of sodium borohydride were kept 
constant. The synthesis was controlled at 0 ⁰C, 9.3×10−3 M PVP and 1.98×10−2 M NaBH4. 
The pH at which the reaction occurred was controlled at pH 5.5, 9.78 or 10.5 for BB11, BB12 
and BB13 respectively. The solutions were prepared and chilled to ice temperature and the 
reaction was carried out on ice. Table 2.10 summarises the reaction conditions and molar 
ratio of PVP/Ag and that of NaBH4/Ag used in the synthesis of samples BB11, BB12 and 
BB13.  
Table 2.10: Investigating the effect of pH. 
 
The pH of a 30 mL 1.98×10
−2
 M NaBH4 aqueous solution was adjusted to pH 5.5, 9.78 or 
10.5 by adding 0.2 M citric acid and 0.1 M NaOH. The solution was poured into an 
Erlenmeyer flask, and then the flask was placed in an ice bath on a stir plate. The solution 
was stirred and cooled for 20 minutes. Then 10 mL of aqueous 3.8×10
−3
 M AgNO3 solution 
was added into the stirring NaBH4 solution at approximately 1 drop per second. Stirring was 
discontinued immediately after adding silver nitrate. Then 0.0148 g PVP was added into 
AgNPs solution and then the solution was stirred to dissolve the PVP.  
Sample  
 
ID 
Silver (µg/mL) NaBH4: Ag PVP: Ag Temperature (⁰C) pH 
BB12 100 16 10 0 5.5 
BB13 100 16 10 0 9.78 
BB14 100 16 10 0 10.5 
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The UV-vis spectroscopy was used to screen all the AgNPs synthesised by varying the 
synthesis conditions. The optimum synthesis parameters that produced a spectrum with a 
narrow full width at half maximum and highest absorbance intensity was chosen in all down-
stream investigations.  
2.2.3. Investigating the effect of light  
From the UV-Vis spectra of the AgNPs, the sample with the smallest particle and narrowest 
size distribution was exposed to a beam of light.  The AgNPs solution (500 mL) was poured 
into a beaker, and then the beaker was placed on a stir plate. The nanoparticle solution was 
stirred and exposed to light using an OSRAM Vitalux lamp (300 W and 230 V) for 1, 3, 6 or 
12 hours and the samples were labelled S1, S2, S3 and S4 respectively. In another set of 
experiments the nanoparticle solution was exposed to light using an OSRAM Vitalux lamp 
(300 W and 230 V) without stirring for 1, 3, 6 or 12 hours and the samples were labelled S5, 
S6, S7 and S8 respectively  
2.3. Silver nanoparticles concentration and purification   
This section investigated ways to concentrate and purify the AgNPs to suite their biological 
application.  
2.3.1. Increasing the starting material to scale-up the concentration of silver 
from 0.1 mg/ml to 1 mg/ml 
The preparation of sample BB14 was carried out at 0 ⁰C, pH 9.78, with a Ag/sodium 
borohydride/PVP molar ratios of 1:16:10. The pH of 0.198 M 1.98×10
−2
 M NaBH4 aqueous 
solution (30 mL) was adjusted to pH 9.78 by adding 0.1 M NaOH. The solution was poured 
into an Erlenmeyer flask, and then the flask was placed in an ice bath on a stir plate. The 
solution was stirred and cooled for 20 minutes. Then 10 mL of aqueous 3.8×10
−2
 M AgNO3 
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solution was added into the stirring NaBH4 solution at approximately 1 drop per second. 
Stirring was discontinued immediately after adding silver nitrate. Then 0.148 g PVP was 
added into the AgNPs solution and the solution was stirred to dissolve the PVP. The resulting 
samples were analysed by UV-vis spectroscopy. 
2.3.2. Concentrating the nanoparticles using the freeze-dry and centrifuge 
techniques 
Silver nanoparticles (40 mL) were freshly synthesised into a 50 mL greiner tube. The 
nanoparticles were synthesised at pH 9.78, at a temperature of 0 ⁰C and Ag/NaBH4/PVP 
molar ratio of 1:16:10. Thirty- millilitres of 1.98×10
−2
 M NaBH4 aqueous solution was 
adjusted to pH 9.78 by adding 0.1 M NaOH. The solution was poured into an Erlenmeyer 
flask, and then the flask was placed in an ice bath on a stir plate. The solution was stirred and 
cooled for 20 minutes. Then 10 mL of aqueous 3.8×10
−3
 M AgNO3 solution was added into 
the stirring NaBH4 solution at approximately 1 drop per second. Stirring was discontinued 
immediately after adding silver nitrate. Then 14.8 mg PVP was dissolved in the AgNPs 
solution.  
The AgNPs solution was emptied into a 50 mL greiner tube, then the tube was sealed with a 
parafilm (with poked holes) and frozen at -80 ⁰C for 6 hours.  Subsequently the tube was 
placed in a freeze drier and the liquid was removed at -50°C for 120 hour. Another batch of 
silver nanoparticles (40 mL) were freshly synthesised as described above and emptied into a 
50 mL greiner tube. The nanoparticle solution was centrifuged at 1300 rpm for 30 minutes.    
2.4. Characterization of silver nanoparticles 
The synthesized silver nanoparticles were characterized using microscopic and spectroscopic 
techniques. High resolution transmission electron microscopy (HR-TEM) was the 
microscopic technique used while the spectroscopic techniques were ultraviolet-visible 
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spectroscopy (UV-vis) and Energy-dispersive X-ray spectroscopy (EDS). In the section that 
follows, a description of the principles, practical aspects as well as instrumentation of all the 
techniques used in this study is given.  
2.4.1. Ultraviolet visible spectroscopy 
In the production of silver nanoparticles: silver ions were reduced to zero valent silver atoms, 
which then self-assembled into silver nanoparticles. Therefore UV-visible spectroscopy could 
qualitatively and quantitatively analyse the silver nanoparticles. This technique predicts the 
particle size, distribution and quantifies the concentration of silver using the Beer-Lamberts 
Law. Freshly prepared samples were used for UV-vis analysis. UV-Vis spectroscopy 
measurements were recorded over a range of 200-600 nm using 3 cm
3
 quartz cuvettes with 
Nicolette Evolution 100 Spectrometer (Thermo Electron Corporation, UK).  
2.4.1.1. Silver nanoparticles size prediction using UV-vis spectroscopy 
interpretation models  
The absorption of light at a particular wavelength is determined by the ratio of transmitted 
light and incident light (I/Io). Therefore absorbance can be expressed as: 
 
This expression implies that each molecule in a solution absorbs a certain amount of light, 
therefore absorbance is directly proportional to the abundance of particles in a solution. Beer-
Lambert Law states that absorbance of a solution is directly proportional to the concentration 
of the absorbing species in the solution and the path length. 
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The parameter A = describes the absorbance, I0 = is the intensity of incident light, I = is the 
intensity of the transmitted light, ε = is the molar absorptivity or extinction coefficient at 
wavelength (λmax) =1.85 X 10
10
 M
-1
 cm
-1 
and L = is the path length. Typically the light path is 
a constant equal to the quartz cell length of 1 cm, while the concentration (c) may vary. The 
law is true for stable homogeneous samples where the physical and chemical state of the 
sample does not change. Therefore Beer-Lambert Law is used for estimation of concentration 
the silver nanoparticles. UV-vis absorption spectroscopy is also an effective technique used 
to study particle growth of nanocrystals giving useful information on the size and particle size 
distribution. Nakaoka and Nosaka, (1997) illustrated the relationship between the radius of a 
particle and its absorption band. The conduction band energy represents the amount of energy 
required to excite the conduction electrons from the lowest energy state to higher energy 
states as influenced by the UV-visible electromagnetic radiation. A good estimation of energy 
resulting from these electronic transitions can be determined by Plank’s law:  
 
Where E = is the energy of light (eV), h = 6.626 x 10
-34
 J s
-1
 is Planks constant, ν = frequency 
of light, c = 2.998 x 10
8
 m s
-1
 is the speed of light and λmax = maximum wavelength (nm). 
Then the particle size can be derived using the effective mass approximation model (Beri et 
al., 2010): 
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Where Eg = is the energy band gap (eV), a = is the particle size, h = 6.626 x 10
-34
 is the 
Plank’s constant, me = 0.17mo is the electron mass, mh = 1.44mo is the hole mass (mo = 
9.1095 x 10
-31
 kg, is the mass of a stationary electron).  
2.4.1.2. Prediction of silver nanoparticles size distribution using UV-vis 
spectroscopy 
The peak width will be used to determine the particle size distribution and compare the 
different synthesis methods used in this study. The full width at half maximum (FWHM) is  
discribed in Figure 2.3. 
 
Figure 2.3: Deriving full width at half maximum (FWHM) from a UV-vis spectra.   
 
The FWHM was measured using the following steps: primarily, a line was drawn connecting 
the maximum of the peak to the baseline (amplitude), then a 90º perpendicular line was 
drawn in the centre of the amplitude. Then the two points of intersection between the 
perpendicular line and the peak were noted. The wavelength difference between the two 
points of intersections was recorded as the FWHM.  
2.4.2. Transmission electron microscopy  
High resolution transmission electron microscopy (HRTEM) analyses the morphology and 
crystallography of the atoms that makeup that particular particle. HRTEM is an imaging tool 
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that directly images nanoparticles therefore providing more information on the quality, size, 
shape, arrangement of the particles and the inter-particle interaction on the scale of atomic 
diameter. The aim of carrying out HRTEM analysis was to confirm the size and morphology 
of the nanocrystals, check if they are agglomerated or dispersed as well as their chemical 
composition. The TEM sample preparation was performed by placing a drop of the silver 
nanoparticle solution onto S147-4 lacey carbon film 400 mesh copper grids and drying the 
mounted sample under an electric bulb for 15 min then allowing the sample to dry maximally 
for 18 hours. Then the HR-TEM images were acquired using a Tecnai G2F2O X-Twin MAT 
200 kV Field Emission Transmission Electron Microscope from FEI (Eindhoven, 
Netherlands). The TEM images were analysed using ImageJ software. The actual size 
distribution of the silver nanoparticles was derived from a histogram which was obtained by 
measuring the diameter of all the particles; about 200 particles were taken into account to 
establish the histogram.  
2.4.3. Energy Dispersive Spectroscopy  
The HR-TEM is coupled with an integral motorized Energy Dispersive Spectroscopy (EDS) 
detector, which allows for insertion and removal into the TEM column for X-ray collection. 
The localised EDS determined the elemental composition of a sample. EDS was used to 
measure the purity and quality of the silver nanoparticles. EDS spectra were collected at 
α=15° and β=0° for every analysis. Bright field images from the regions of interest were 
obtained with the sample at zero tilt. The desired counts per second were between 1000 - 
4000 and the detector dead time was maintained between 30 % - 40 %. 
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2.5. Investigating the antibacterial properties of silver nanoparticles 
The nanoparticles with uniform size distribution and morphology were chosen for further 
analysis. The antibacterial activity of the silver nanoparticles was investigated on Escherichia 
coli 1699, Staphylococcus epidermidis, Bacillus cereus, Mycobacterium smegmatis, 
Cupriavidus metallidurans. Chloramphenicol was used as a positive control in order to 
demonstrate growth inhibition. The sample preparation, medium preparation, minimum 
inhibitory concentration procedure, growth curve procedures and TEM analysis procedure are 
detailed below.  
2.5.1. Media Preparation 
Tryptic soy broth (TSB) medium was prepared by dissolving 30 g of tryptic soy broth in 800 
mL of distilled water and made up to the final volume of 1 litre. Casamino acid-Peptone-
Glucose (CPG) medium was prepared by dissolving 1 g of casamino acid, 10 g of peptone 
powder and 5 g of glucose in 800 mL of distilled water and made up to the final volume of 1 
litre. The Luria broth (LB) medium was prepared by dissolving 10 g tryptone powder, 5 g 
yeast extract and 10 g NaCl in 800 mL of distilled water and made up to the final volume of 1 
litre. The solutions were autoclaved for 20 minute at 121 ⁰C and allowed to cool to room 
temperature.  
2.5.2. Growth of Bacteria 
2.5.2.1. Overnight cultures 
Overnight cultures were prepared by aliquoting 5 mL of media into sterile McCartney glass 
bottles and inoculated from a -80 ⁰C glycerol stock. The bacteria were inoculated in the 
respective media E. coli in LB, C. metallidurans in CPG, and M. smegmatis, S. epidermidis 
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and B. cereus in TSB [Table 2.11]. The cultures were incubated at 37 ⁰C with shaking at 250 
rpm, overnight.  
Table 2.11: The bacteria used in this study and their corresponding growth media. 
Name of the media Bacterial strains 
Luria broth (LB) E. coli 
Casamino-acid peptone glucose  C. metallidurans 
Tryptic soy broth B. cereus 
 M. smegmatis 
 S. epidermidis 
 
2.5.2.2. Minimum inhibitory concentration of silver nanoparticles   
Antibacterial activity of the AgNPs at different silver concentrations was determined by a 
microtitre well plate method (Jaiswal et al., 2010).  
The nanoparticles could not be purified from the by-products of the synthesis such as boron, 
sodium, nitrites and the alkaline pH. In order to be precise about the silver nanoparticles’ 
cidal effects, control experiments were performed. The equation below predicts the by-
products in the synthesis of AgNPs using sodium borohydride.    
AgNO3 + NaBH4                          Ag + 
1
/2H2 + 
1
/2 B2H6 + NaNO3  
Experimental controls in respect to the expected amount of the by-product in a silver 
nanoparticles colloidal suspension were performed. The by-product stock solution contained 
19.77 mM NaBH4, 9.27 mM PVP and 0.927 mM NaNO3 and was freshly prepared and stored 
at 4 °C prior to use.  An additional control, silver nitrate, was included in order to test the 
efficacy/toxicity of the silver nanoparticles in relation to silver ions. AgNPs (100 mg/L) stock 
solution was also freshly prepared and stored at 4 °C prior to use. Bacteria were cultured in 
microtitre well plates with varying concentrations of the stock solutions (by-products, Ag
+
 or 
AgNPs) [Table 2.12].  
In the preparation of 0, 10, 20, 30, 40, 50, 60 and 70 mg/L of treatment titration (Ag
+
, AgNPs 
or by-products) respective volumes of sterile distilled water (175, 155, 135, 115, 95, 75, 55 
and 34 µL) were added into a 96-well plate. Subsequently 0, 20, 40, 60, 80, 100, 120 and 140 
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µL of the treatment (AgNPs, Ag+ or by-products) were added (0, 10, 20, 30, 40, 50, 60 and 
70 mg/L treatment) in the respective wells. Separately, 5 µL of the overnight culture was 
inoculated into 20 µL of ten times concentrated bacterial growth media. Then 25 µl of the 
inoculums (10X growth media inoculated with bacteria from the overnight culture) was 
added on the respective wells [Table 2.12]. The experiment was done in triplicates. 
Table 2.12: A representation of amount of materials added in each well in a 96 well plate in the minimum 
inhibitory concentration experiment  
Stock solution (v/v) 0 0.05 0.1 0.15 2 2.5 3 3.5 
Treatment agent (µL) 
(AgNPs; AgNO3 and by-products) 
0 20 40 60 80 100 120 140 
dH2O (µL) 175 155 135 115 95 75 55 35 
10X bacterial growth media (µL) 20 20 20 20 20 20 20 20 
Overnight culture (µL) 5 5 5 5 5 5 5 5 
 
The cultures were incubated at 37 ⁰C while shaking at 250 rpm and then optical density (OD) 
readings were taken before the incubation and after 24 hours of incubation. To determine the 
minimum inhibitory concentration (MIC) an OD (t = 0 and t = 24 hours) vs time bar graph 
was plotted. The MIC reported is the minimum concentration of AgNPs, Ag
+
 or by-product 
which resulted in complete lack of growth. 
2.5.2.3. Growth curves 
Fresh medium (100 ml media in 250 ml Erlenmeyer flask in triplicate) was inoculated with 
50 µl of the overnight culture, and the flasks were incubated at 37 ⁰C while shaking at 250 
rpm for 24 hours. The population growth (optical density) was then monitored every 2 hours 
by spectrophotometric reading at 600 nm.  
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2.6. Structural characterisation of bacteria using transmission electron 
microscope (TEM) 
TEM was used to visualise the surface damage caused by silver nanoparticles on the bacteria 
and possible nanoparticle attachment and accumulation as has been demonstrated by 
Morones et al., (2005). 
2.6.1. Cell treatment and harvesting 
An overnight culture was prepared as in section 2.5.2.1. Fifty microlitres of overnight culture 
was inoculated into 100 ml of fresh media in a 250 ml Erlenmeyer flask. At mid-logarithmic 
growth (OD = 0.45) the bacterial culture was treated with 20 mg/L silver nanoparticles and 
the culture incubated at 37 ⁰C for an hour. The bacteria were harvested by aliquoting the 
culture in 2 mL eppendorf tubes and pelleting the cells at 1300 rpm for 10 minutes. Prior to 
the fixation step, the cells were washed by resuspending the pellet in water and then 
centrifuging for another 10 minutes at 1300 rpm.  
2.6.2. Cell fixation 
The cells were fixed by adding 2.5% glutaraldehyde in phosphate buffered saline (PBS) 
buffer and the cells were incubated at 4 ⁰C overnight. Cells were collected by centrifugation 
(10,000 rpm, 5 min) and washed twice with 0.1 M PBS buffer (by centrifugation at 10000 
rpm for 15 sec). For final fixing of cells, 1% osmium tetroxide in PBS was added and 
samples were held at 25 ⁰C for 1 hour. Subsequently the cells were washed twice with 0.1 M 
PBS (centrifuge at 10000 rpm for 10 min in between the washing steps) followed by two 
washings with ddH2O (centrifuge at 10000 rpm for 10 min). Thereafter the cells were 
dehydrated with ethanol.  
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2.6.3. Dehydration  
The pellet was washed with 30 % ethanol then centrifuged at 10000 rpm for 10 min and the 
liquid was discarded. Sequentially the same was done for the 50 %, 60 %, 70 %, 80 %, 90 %, 
95 %, 100 % ethanol dehydration steps preceding the 100 % acetone wash. The dehydrated 
cells were flooded with a mixture of resin/ acetone ratio of 1:1 and incubated at 25 ⁰C 
overnight. 
2.6.4. Resin treatment 
The cells were centrifuged at 10000 rpm for 5 min and the liquid was discarded. The pellet 
was flooded with a mixture of resin/acetone ratio of 3:1 and incubated at 25 ⁰C in a rotator 
for 5 hours. The liquid was discarded prior to the addition of 100 % resin and the cells were 
incubated at 25 ⁰C in a rotator overnight. The cells were transferred into a mould and put in 
an oven (60 ⁰C) overnight. The polymerised cells settling in the apex of the mould were cut 
into sections using a diamond knife.  
2.6.5. Transmission electron microscopy and energy dispersive spectroscopy analysis 
The thin layers of sample (cut as described above) were fixed to a TEM copper grid and TEM 
sample analysis was performed.  Electron micrographs of untreated cells and AgNP-treated 
bacteria were taken using a Zeiss EM 900 transmission electron microscope (Zeiss, 
Germany). EDS Spectra were collected at α=15° and β=0°. Bright field images from the 
regions of interest were obtained with the sample at zero tilt. The desired counts per second 
were between 1000 - 4000 and the detector dead time was maintained between 30 % - 40 %. 
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Chapter 3 
Characterisation of silver nanoparticles 
3.1. Introduction 
The synthesis of small and uniformly sized nanoparticles still remains a challenge, hence this 
study aimed to synthesise small and uniform nanoparticles. These nanostructures exhibit 
unique properties due to their large surface to volume ratios compared to bulk materials or 
individual molecules in suspension. Silver Nanoparticles were synthesized by a wet chemical 
technique through the reduction of silver ions by ascorbic acid or sodium borohydride as 
described in section 2.2 previously. Then the reaction conditions, including temperature, pH 
and the amount of reducing agent and that of stabilising agent, were varied to control the 
nanoparticles size and size distribution. This chapter is divided into five parts: Firstly, the 
Ultraviolet-visible spectra analysis of AgNPs (synthesised by ascorbic acid or sodium 
borohydride while varying the reaction conditions mentioned previously) is presented. 
Secondly, a comparative analysis of the two reducing agents (ascorbic acid and sodium 
borohydride) is given. Thirdly, the size of AgNPs synthesised by sodium borohydride is 
confirmed using transmission electron microscopy. Fourthly, the EDS analysis of AgNPs 
resulting from the synthesis that produced small and uniform AgNPs is presented. Lastly, the 
stability, concentrating, purification and isolation studies will be detailed.  
3.2. Characterisation of silver nanoparticles using Ultraviolet-visible 
spectroscopy 
When an object is subjected to a beam of light it absorbs some photons while others get 
transmitted, scattered or reflected; therefore measuring the interaction of light with the object 
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can predict the presence and size of that object. The absorption patterns of AgNPs, with 
peaks between 350 - 450 nm confirmed successful synthesis of AgNPs (Vigneshwaran et al., 
2006). Full width at a half maximum (FWHM) described in section 2.4.1, predicts the 
variation in particle size distribution. The maximum absorbance (λmax) indicates the 
wavelength at which the nanoparticles absorb and a shift towards longer wavelengths 
represents an increase in average particle size.  
3.2.1. Characterisation of AgNPs synthesised by ascorbic acid using ultraviolet-
visible spectroscopy 
The resulting AgNPs synthesised using ascorbic acid and sodium borohydride as described in 
section 2.2.1 and 2.2.2 respectively were characterised using UV-vis spectroscopy. The 
average particle size and their distribution were determined as detailed in section 2.4.1.1 and 
2.4.1.2 respectively. 
3.2.1.1. The effect of ascorbic acid on the size of AgNPs 
The effect of the reducing agent on the silver nanoparticle’s size was investigated by varying 
the concentration of ascorbic acid (4.635 x 10
-4
 M, 1.39 x 10
-3
 M and 1.85 x 10
-3
 M ascorbic 
acid for AA1, AA2 and AA3 respectively). Other reaction parameters were controlled at 30 
⁰C, pH 10.5 and 2.781 x 10-3 M citric acid as described in section 2.2.1.1. Figure 3.1 shows 
the UV-vis spectra of AA1, AA2 and AA3. Table 3.1 presents the size and particle size 
distribution of AgNPs in samples AA1, AA2 and AA3.  
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Figure 3.1: The UV-vis spectra of samples AA1, AA2 and AA3 showing the effect of varying the concentration of 
the reductant, ascorbic acid. 
 
Table 3.1: Analysis of UV-vis spectra of samples AA1, AA2 and AA3. 
Sample ID 
Varied synthesis condition 
(Molar ratio) 
λ max Absorbance intensity (u.a) FWHM Particle size (nm) 
AA1 
Ag: Ascorbic acid 
1:1 430 nm 1.5 110 22.6 
AA2 1:3 430 nm 1.1 170 22.6 
AA3 1:4 435 nm 1.4 115 24.5 
 
The particle size distributions, represented by the full width at a half maximum (FWHM), 
was independent of the amount of ascorbic acid since Sample AA1, AA2 and AA3 had 110 
nm, 170 nm and 115 nm FWHM respectively. However, the particle size increased as the 
amount of ascorbic acid increased, sample AA1, AA2 and AA3 produced 22.6, 22.6 and 24.5 
nm AgNPs respectively. Low concentrations of ascorbic acid (sample AA1) produced smaller 
AgNPs, with a narrow particle size distribution. 
3.2.1.2. The effect of stabilising agent on the size of AgNPs 
3.2.1.2.1. The effect of citric acid on the size of AgNPs 
The effect of the stabilising agent on the silver nanoparticles size was investigated by varying 
the concentration of citric acid (0 M, 2.781 x 10
-3
 M and 9.27 x 10
-3
 M citric acid for AA4, 
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AA5 and AA6 respectively). Other reaction parameters were controlled at 30 ⁰C, pH 10.5 and 
4.634 x 10
-4
 M ascorbic acid as described in section 2.2.1.2.1. Figure 3.2 shows the UV-vis 
spectra of AA4, AA5 and AA6. Table 3.2 presents the size and particle size distribution of 
AgNPs in samples AA4, AA5 and AA6.  
 
Figure 3.2: The UV-vis spectra of samples AA4, AA5 and AA6 showing the effect of varying the amount of 
stabilising agent, citric acid. 
 
Table 3.2: Analysis of UV-vis spectra of samples AA4, AA5 and AA6. 
Sample ID 
Varied synthesis condition 
(Molar ratio) 
λ max Absorbance intensity (u.a) FWHM Particle size (nm) 
AA4 
Ag: Citric acid 
0 430 nm 1.5 105 22.6 
AA5 1:3 435 nm 2.5 115 22.5 
AA6 1:10 440 nm 1.1 125 26.4 
 
The quantity of AgNPs (absorbance intensity) was affected by high or low amounts of citric 
acid therefore sample AA5 yielded more AgNPs with absorbance intensity of 2.5 u.a. Minute 
amounts of citric acid (sample AA5) preserved the AgNPs, producing a particle size of 22.5 
nm AgNPs. However, high concentrations of citric acid (sample AA6) collapsed the stability 
of the AgNPs resulting in increased particle size from 22.6 nm (uncoated AgNPs) to 26.4 nm. 
Citric acid creates a negatively charged thick electric double layer around the particle in low 
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ionic strength water, therefore causing inter-particle repulsion. However, high concentration 
can vastly affect optimum pH that aids in the reduction efficiency of ascorbic acid or the 
stability of AgNPs. 
3.2.1.2.2. The effect of PVP on the size of AgNPs 
The effect of the stabilising agent on the silver nanoparticles size was investigated by varying 
the concentration of PVP (0 M, 2.781 x 10
-3
 M and 9.27 x 10
-3
 M PVP for AA4, AA7 and 
AA8 respectively). Other reaction parameters were controlled at 30 ⁰C, pH 10.5 and 4.634 x 
10
-4
 M ascorbic acid as described in section 2.2.1.2.2. Figure 3.3 shows the UV-vis spectra of 
AA4, AA7 and AA8. Table 3.3 presents the size and particle size distribution of AgNPs in 
samples AA4, AA7 and AA8.  
 
Figure 3.3: The UV-vis spectra of samples AA4, AA7 and AA8 showing the effect of varying the amount of 
stabilising agent, PVP. 
 
Table 3.3: Analysis of UV-vis spectra of samples AA4, AA7 and AA8. 
Sample ID 
Varied synthesis condition  
(Molar ratio) 
λ max Absorbance intensity (u.a) FWHM Particle size (nm) 
AA4 
Ag: PVP 
0 430 nm 1.5 105 22.6 
AA7 1:3 435 nm 0.4 200 25.5 
AA8 1:10 None None None None 
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PVP was not a good stabilising agent for the AgNPs synthesised by ascorbic acid. The 
addition of PVP caused a shift in the UV-vis spectrum to longer wavelengths from 430 nm to 
435 nm, depicting agglomeration of particles. Furthermore, minute amounts of PVP (sample 
AA7) depleted the number of AgNPs (absorbance intensity of naked AgNPs (1.5 u.a.) which 
decreased to 0.4 u.a. following addition of PVP). Increasing the amount of PVP completely 
agglomerated the particles, hence sample AA8 did not absorb in this region. The PVP 
collapsed the strength of the solution to hold the AgNPs in dispersion therefore caused a 
decrease in Gibbs energy and causing particle agglomeration.  
3.2.1.3. The effect of temperature on the size of AgNPs 
The effect of the temperature on the silver nanoparticles size was investigated by varying the 
temperature (25, 30 and 50 ⁰C for AA9, AA10 and AA11 respectively). Other reaction 
parameters were controlled at pH 10.5, 2.781 x 10
-3
 M citric acid and 4.634 x 10
-4
 M ascorbic 
acid as described in section 2.2.1.3 Figure 3.4 shows the UV-vis spectra of AA9, AA10 and 
AA11. Table 3.4 presents the size and particle size distribution of AgNPs in samples AA9, 
AA10 and AA11. 
  
Figure 3.4: The UV-vis spectra of samples AA9, AA10 and AA11 showing the effect of varying the temperature. 
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Table 3.4: Analysis of UV-vis spectra of samples AA9, AA10 and AA11. 
Sample ID Varied synthesis condition λ max Absorbance intensity (u.a) FWHM Particle size (nm) 
AA9 
Temperature (⁰C) 
25 None None None None 
AA10 30 435 nm 1.5 115 24.5 
AA11 50 None None None None 
 
AA9 and AA11 proved that temperature is very crucial in the synthesis of AgNPs by ascorbic 
acid. The Ag
+ 
were not reduced at 25 ⁰C (AA9) and 50 ⁰C (AA11) whereas the synthesis at 
30 ⁰C (AA10) successfully produced AgNPs. Controlling the temperature at 30 ⁰C (AA10) 
produced 24.5 nm AgNPs. The reduction of Ag
+
 by ascorbic acid is an endothermic reaction 
therefore 30 ⁰C supplied enough energy for the reaction to occur. Very high temperatures are 
associated with increasing the rate of a reaction which facilitated particle agglomeration 
hence the sample did not absorb in the UV-visible region.  
 
3.2.1.4. The effect of pH on the size of AgNPs 
The effect of the pH on the silver nanoparticles size was investigated by varying the pH (pH 
5.5, 9.78 and 10.5 for AA12, AA13 and AA14 respectively). Other reaction parameters were 
controlled at 30 ⁰C, 2.781 x 10-3 M citric acid and 4.634 x 10-4 M ascorbic acid as described 
in section 2.2.1.4. Figure 3.5 shows the UV-vis spectra of AA12, AA13 and AA14. Table 3.5 
presents the size and particle size distribution of AgNPs in samples AA12, AA13 and AA14. 
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Figure 3.5: The UV-vis spectra of samples AA12, AA13 and AA14 showing the effect of pH variation. 
 
Table 3.5: Analysis of UV-vis spectra of samples AA12, AA13 and AA14. 
Sample ID Varied synthesis condition λ max Absorbance intensity (u.a) FWHM Particle size (nm) 
AA12 
pH 
5.5 420 nm 0.55 125 18.8 
AA13 9.78 425 nm 1 125 20.7 
AA14 10.5 435 nm 1.5 115 24.5 
 
There was a Red shift in the absorption peak as the pH increased, AgNPs produced at pH 5.5, 
pH 9.78 and 10.5 absorbed at 420, 425 and 435 nm respectively. The particle size also 
increased as the pH increased producing 18.8 nm, 20.7 nm and 24.5 nm AgNPs at pH 5.5 
(AA12), 9 (AA13) and 10.5 (AA14) respectively. pH 10.5 (sample AA14) yielded more 
AgNPs (1.5 a.u. absorbance intensity) with uniform particle size distribution (FWHM = 115 
nm) compared to both pH 5.5 (sample 12) and pH 9.78 (sample 13).  
3.2.2. Characterisation of AgNPs synthesised by sodium borohydride using 
ultraviolet-visible spectroscopy 
The AgNPs were synthesised through the reduction of AgNO3 by sodium borohydride while 
varying the concentration of the reducing (sodium borohydride) and stabilising (citric acid or 
PVP) agent, temperature and pH.  
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3.2.2.1. The effect of sodium borohydride on the size of AgNPs 
The amount of sodium borohydride was varied (4.635 x 10
-4
 M, 1.39 x 10
-3
 M and 1.85 x 10
-3
 
M sodium borohydride in sample BB1, BB2 and BB3 respectively) in order to investigate the 
effect of sodium borohydride on the silver nanoparticles size. Other reaction parameters were 
controlled at 0 ⁰C, pH 9.78 and 29.27x10-3 M PVP as described in section 2.2.2.1. Figure 3.6 
and Table 3.6 shows the UV-vis spectra and the measured size and particle size distribution 
of AgNPs in samples BB1, BB2 and BB3. 
 
Figure 3.6: The UV-vis spectra of samples BB1, BB2 and BB3 showing the effect varying the amount of the 
reductant, sodium borohydride. 
 
Table 3.6: Analysis of UV-vis spectra of samples BB1, BB2 and BB3. 
Sample ID 
Varied synthesis condition 
(Molar ratio) 
λ max Absorbance intensity FWHM 
Particle size 
(nm) 
BB1 
Ag:NaBH4 
1:1 385 nm 2.8 130 7.3 
BB2 1:10 390 nm 2.7 100 7.33 
BB3 1:16 390 nm 3.15 90 7.33 
 
Changing the amount of sodium borohydride did not show a significant difference in the size 
of AgNPs (BB1, BB2 and BB3 yielded 7.33 nm, 7.33 nm and 7.3 nm AgNPs respectively) 
produced, rather it improved the particle size distribution (BB1, BB2 and BB3 yielding 
 
 
 
 
72 | P a g e  
 
AgNPs with a FWHM of 130 nm, 100 nm and 90 nm respectively). Sample BB3 also had a 
maximum yield (3.15 a.u.) and the narrowest particle size distribution.  
3.2.2.2. The effect of stabilising agent of the size of AgNPs 
3.2.2.2.1. The effect of citric acid on the size of AgNPs 
The effect of citric acid as a stabiliser on the size of silver nanoparticles was investigated by 
varying its concentration (0 M, 2.781x10
-3
 M and 9.27x10
-3
 M citric acid in sample BB4, 
BB5 and BB6 respectively). Other reaction parameters were controlled at 0 ⁰C, pH 9.78 and 
1.85 x 10
-3
 M sodium borohydride as described in section 2.2.2.2.1. Figure 3.7 and Table 3.7 
show the UV-vis spectra and the measured size and particle size distribution of AgNPs in 
samples BB4, BB5 and BB6. 
 
Figure 3.7: The UV-vis spectra of samples BB4, BB5 and BB6 showing the effect of varying the concentration of 
stabilising agent, citric acid. 
 
Table 3.7: Analysis of UV-vis spectra of samples BB4, BB5 and BB6. 
Sample ID 
Varied synthesis condition 
(Molar ratio) 
λ max Absorbance intensity FWHM 
Particle size 
(nm) 
BB4 
Citric acid: Ag 
0 385 nm 2.65 75 5.4 
BB5 3 390 nm 1.2 60 6.7 
BB6 10 None None None None 
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The stabilising agent (citric acid) had an effect on the quality of AgNPs produced. The 
addition of citric acid to the borohydride system caused depletion of the nanoparticles as 
shown by the absorbance intensity (2.65, 1.2 and 0 a.u. in samples BB4, BB5 and BB6 
respectively) but low concentrations of citric acid improved particle size distribution (FWHM 
= 75 nm and 60 nm for samples BB4 and BB5 respectively). A Red shift in the absorption 
spectra following the addition of citric acid (sample BB5) is an indication of agglomeration 
therefore increasing the size of the particles (5.4 and 6.7 nm in samples BB4 and BB5 
respectively).  
3.2.2.2.2. The effect of PVP on the size of AgNPs 
The effect of PVP as a stabiliser on the size of silver nanoparticles was investigated by 
varying its concentration (0 M, 2.781x10
-3
 M and 9.27x10
-3
 M PVP in sample BB4, BB7 and 
BB8 respectively). Other reaction parameters were controlled at 0 ⁰C, pH 9.78 and 1.85 x 10-
3
 M sodium borohydride as described in section 2.2.2.2.2. Figure 3.8 and Table 3.8 show the 
UV-vis spectra and the measured size and particle size distribution of AgNPs in samples 
BB4, BB7 and BB8. 
 
Figure 3.8: The UV-vis spectra of samples BB4, BB7 and BB8 showing the effect of varying the amount of 
stabilising agent, PVP. 
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Table 3.8: Analysis of UV-vis spectra of samples BB4, BB7 and BB8. 
Sample ID 
Varied synthesis condition 
(Molar ratio) 
λ max Absorbance intensity (u.a.) FWHM 
Particle 
size (nm) 
BB4 
Ag:PVP 
0 385 nm 2.65 75 5.4 
BB7 1:3 390 nm 2.45 85 7.3 
BB8 1:10 390 nm 3.15 90 7.3 
 
The addition of PVP increased the particles size from 5.4 nm (BB4) to 7.3 nm (BB7 and 
BB8) and also broadened the particle size distribution (FWHM = 75, 85 and 90 nm for 
samples BB4, BB7 and BB8 respectively).  
3.2.2.3. The effect of temperature on the size of AgNPs 
The effect of temperature on the size of silver nanoparticles was investigated by controlling 
the synthesis temperatures at 0 ⁰C, 25 ⁰C and 50 ⁰C for samples BB9, BB10 and BB11 
respectively. Other reaction parameters were controlled at pH 9.78, 9.27x10
-3
 M PVP and 
1.85 x 10
-3
 M sodium borohydride as described in section 2.2.2.3. Figure 3.9 and Table 3.9 
show the UV-vis spectra and the measured size and particle size distribution of AgNPs in 
samples BB9, BB10 and BB11. 
 
Figure 3.9: The UV-vis spectra of samples BB9, BB10 and BB11 showing the effect of varying the temperature. 
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Table 3.9: Analysis of UV-vis spectra of samples BB9, BB10 and BB11. 
Sample ID Varied synthesis condition λ max Absorbance intensity FWHM 
Particle size 
(nm) 
BB9 
Temperature (⁰C) 
0 390 nm 3.15 90 7.3 
BB10 25 390 nm 2.95 95 7.3 
BB11 50 None None None None 
 
Temperature is very crucial in the synthesis of AgNPs by sodium borohydride. The synthesis 
carried out at 0 ⁰C (BB9) and 25 ⁰C (BB10) produced 7.3 nm AgNPs although sample BB10 
had a wider size distribution (FWHM = 95 nm) than BB9 (FWHM = 90 nm). The 
nanoparticles produced at 50 ⁰C (BB11) did not absorb in the wavelength range for silver 
nanoparticles. 
3.2.2.4. The effect of pH on the size of AgNPs 
The effect of pH on the size of silver nanoparticles was investigated by controlling the 
synthesis pH at 5.5, 9.78 and 10.5 for samples BB12, BB13 and BB14 respectively. Other 
reaction parameters were controlled at 0 ⁰C, 9.27x10-3 M PVP and 1.85 x 10-3 M sodium 
borohydride as described in section 2.2.2.4. Figure 3.10 and Table 3.10 show the UV-vis 
spectra and the measured size and particle size distribution of AgNPs in samples BB12, 
BB13 and BB14. 
  
Figure 3.10: The UV-vis spectra of samples BB12, BB13 and BB14 showing the effect of varying pH. 
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Table 3.10: Analysis of UV-vis spectra of samples BB12, BB13 and BB14. 
Sample ID Varied synthesis condition λ max Absorbance intensity FWHM 
Particle size 
(nm) 
BB12 
pH 
5.5 385 nm 0.5 200 5.4 
BB13 9.78 390 nm 3.15 85 7.3 
BB14 10.5 405 nm 2 90 13.1 
 
The particle size increased as the pH increased producing 5.42 nm, 7.33 nm and 13 nm 
AgNPs at pH 5.5 (BB12), 9.78 (BB13) and 10.5 (BB14) respectively. Sample BB13 had a 
fine size distribution (FWHM = 85 nm) compared to the sample BB12 (FWHM = 200 nm) 
and BB14 (FWHM = 90 nm). Sample BB13 also had the highest yield of AgNPs with an 
absorbance intensity of 3.15 u.a. 
3.2.3. Comparative study of silver nanoparticles synthesised with sodium 
borohydride and ascorbic acid  
Figure 3.11 and 3.11 show the size and particle size distribution (FWHM) of AgNPs 
synthesised by ascorbic acid (sample AA1 to AA14) and sodium borohydride (BB1 to BB14) 
respectively. The reaction conditions were varied as described in section 2.2.  
 
Figure 3.11: The size of AgNPs synthesised through reduction by ascorbic acid (AgNPs-AA) and sodium 
borohydride (AgNPs-BB). 
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Figure 3.12: The peak width of the UV-vis spectra of AgNPs synthesised through reduction by ascorbic acid 
(AgNPs-AA) and sodium borohydride (AgNPs-BB). 
 
The reduction of silver ions with ascorbic acid produced silver nanoparticles ranging between 
18.8 and 26.4 nm; whereas the nanoparticles produced by sodium borohydride ranged 
between 5.4 nm and 13.1 nm. The UV-vis spectra of AgNPs synthesised by ascorbic acid had 
a FWHM ranging between 105 nm and 200 nm; whereas the FWHM of nanoparticles 
produced by sodium borohydride ranged between 60 nm and 130 nm. Therefore sodium 
borhydride produced nanoparticles with small and uniform AgNPs compared to ascorbic 
acid. 
Some parameters (amount of reducing and stabilising agent, temperature and pH) were able 
to control the AgNPs size and particle size distribution. The increase in the amount of 
reducing agent in the sodium borohydride synthesis caused a gradual narrowing of particle 
size distribution (samples BB1, BB2 and BB3 had 130, 100, and 90 nm FWHM). Ascorbic 
acid produced AgNPs were best stabilised with citric acid compared to PVP whereas the 
sodium borohydride produced AgNPs were best stabilised with PVP compared to citric acid. 
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The AgNPs stabilised with either citric acid or PVP (samples AA5, AA6, BB5 and BB6,) 
were larger in size compared to the non-stabilised AgNPs (samples AA4 and BB4).The 1:3 
(Ag: citric acid) molar ratio yielded more AgNPs (sample AA5 with the absorbance intensity 
of 2.5 u.a) compared to the non-stabilised AgNPs (sample AA4 with the absorbance intensity 
of 1.5 u.a) in the ascorbic acid synthesis. Ascorbic acid could only synthesis AgNPs at 30 ⁰C 
whereas sodium borohydride had successfully produced AgNPs at 0 ⁰C and 25 ⁰C with the 
maximum yield at 0 ⁰C. The particle size was influenced by pH in both the ascorbic acid and 
sodium borohydride based syntheses. Acidic pH conditions (pH 5.5) resulted in smaller 
AgNPs compared to the alkaline pH (9-10.5) on both syntheses. However, the acidic pH 
resulted in AgNPs with a wide particle size distribution compared to the alkaline pH on both 
syntheses.  
The synthesis condition that produced smaller, uniform particles and the highest absorption 
intensity was chosen to compare the efficacy of each reducing agent (ascorbic acid or sodium 
borohydride). Sample AA5, synthesised at pH 10.5, the temperature of 30 ⁰C, and 
Ag/ascorbic acid/citric acid molar ratio of 1:4:3; was chosen because it produced small and 
uniform AgNPs in the ascorbic acid based synthesis. Sample BB3, synthesised at pH 9.78, 
the temperature of 0 ⁰C, and Ag/NaBH4/PVP molar ratio of 1:10:10; was chosen because it 
produced small and uniform AgNPs in the sodium borohydride based synthesis. Figure 3.13 
shows the TEM images and EDS spectra of AgNPs synthesised by sodium borohydride 
(BB3) or ascorbic acid (AA5). 
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Figure 3.13: Transmission electron micrographs of silver nanoparticles. 
 A) TEM image with EDS spectra of AgNPs synthesised by ascorbic acid as reducing agent. B) The size 
distribution of AgNPs synthesised by ascorbic acid as reducing agent. C) TEM image with EDS spectra of AgNPs 
synthesised by sodium borohydride as reducing agent. D) The size distribution of AgNPs synthesised by sodium 
borohydride as reducing agent.  
 
The UV-vis spectroscopy determined the average particle size of AgNPs synthesised by 
ascorbic acid (AA5) or sodium borohydride (BB3) to be 22.6 nm and 7.3 nm respectively 
[Table 3.2 and Table 3.6]. Transmission electron microscopic images revealed silver 
nanoparticles synthesised by ascorbic acid were relatively larger with a wider size 
distribution (15.4±11.15 nm) compared to nanoparticles synthesised by sodium borohydride 
which were small and uniform in size (6.6±2.6 nm). Both syntheses produced spherical 
particles that were confirmed by EDS to be silver nanoparticles. The EDS spectrum has a 
strong signal in the silver region with a typical optical absorption band peaked nearly at 3 
KeV confirming the metallic silver nanoparticles due to surface plasmon resonance. The 
nanoparticles had an oxide layer as indicated by the presence of a distinct oxygen peak. The 
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EDS spectra also presented with copper (Cu) and carbon (C) which is derived from the 
copper grids coated with a carbon film that was used in the analysis, as described in section 
2.4.2. The peak for silicon (Si) in the EDS spectra originates from the detector and other parts 
of the microscope which may have been exited by the X-rays in the analysis. Sample BB3 
was used for further analysis. 
3.2.4. Investigating the effect of light  
3.2.4.1. The effect of light exposure on AgNPs in motion 
Sample BB3 (synthesis described in section 2.2.2.1) was exposed to light for 0, 6 and 12 
hours as described in section 2.2.3. Figure 3.14 shows TEM images of AgNPs (samples S1, 
S2 and S3) that were exposed to light for different periods of time (0, 6 and 12 h respectively) 
while stirring. Figure 3.14, shows a high resolution image of a single silver nanoparticle that 
was expose to light for 6 hours while stirring (sample S2). 
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Figure 3.14: The morphological changes that AgNPs develop when exposed to light (while stirring). 
A) The TEM images of spherical AgNPs that were not exposed to light (S1). B) The TEM images of icosahedral 
AgNPs that were exposed to light for 6 hours (S2). C) The TEM images of AgNPs that were exposed to light for 
12 hours (S3). D) The high resolution TEM images of icosahedral AgNPs that were exposed to light for 6 hours 
(S2). 
 
Exposing the particles to light for 6 h changed particle shape without a significant alteration 
of size. The 6±1.8 nm spherical AgNPs increased in size to 6±2 nm icosahedral AgNPs 
within 6 h of exposure to light (while stirring) [Figure 3.14 (B)]. However, the particles  
agglomerated into strings by 12 h of light exposure making it difficult to determine their 
shape and size [Figure 3.14 C]. Stirring the AgNPs caused particle agglomeration. Cao, 
(2004) explain this phenomenon by stating that small particles have a high surface to volume 
ratio and therefore are highly reactive. Allowing the reaction of sodium borohydride to occur 
over a long time and constantly stirring would promote nanoparticles interaction and 
ultimately agglomeration.  
A B 
C D 
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3.2.4.2. The effect of light exposure on stationary AgNPs 
Figure 3.15 represents the TEM images of AgNPs that were exposed to light for different 
periods of time (0, 6 and 12 hours for S4, S5 and S6 respectively) without stirring.  
 
Figure 3.15: The morphological changes that stationary AgNPs develop when exposed to light. 
A) The TEM images of spherical AgNPs that were not exposed to light (S4). B) The TEM images of spheres, 
icosahedral and irregular AgNPs that were exposed to light for 6 hours (S5).C) The TEM images of spheres, 
icosahedral, tubes and irregular AgNPs that were exposed to light for 12 hours (S6).  
 
The particles increased in sizes but did not show signs of particle collision or agglomeration. 
Exposing the particles for 6 h (without stirring) did not change particle shape rather increased 
their size. Increasing the light exposure time to 12 h caused an increase in particles size and 
altered their morphology to form rods, spheres and icosahedral shapes. This indicated that 
light has a shape changing effect on the AgNPs at a much slower rate when the particles are 
stationary. Keeping the AgNPs stationary delayed the shape change period and it also 
favoured the formation of different shapes, with a wide size distribution. 
3.2.5. Concentration and purification of the silver nanoparticles 
3.2.5.1. The effect of up-scaling the concentration of silver from 100 µg/ml to 1 
mg/ml 
Samples BB3 and BB14 were synthesised as described in 2.2.2.1 and 2.3.1 respectively. 
Sample BB14 (1 g/L AgNPs) was ten times concentrated than sample BB3 (100 mg/L 
A C B 
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AgNPs). Figure 3.16 shows the optical properties of samples BB3 (100 mg/L AgNPs) and 
BB14 (1 g/L) after 24 hours of storage at 4 ⁰C. 
          
Figure 3.16: The optical properties of 1 g/L AgNPs and 100 mg/L AgNPs after 24 h storage.  
A) The colour and UV-vis spectra of AgNPs immediately after synthesis.  B)  The colour change and UV-vis 
spectra of AgNPs after 24 h of storage at 4 ⁰C. 
 
UV-vis spectroscopy analysis, immediately after the synthesis, showed low absorption 
intensity in 1 g/L AgNPs (2.25 a.u.) compared to the 100 mg/L AgNPs (3.2 a.u.) [Figure 3.16 
(B)]. Then there was a visual colour change in the 1 g/L AgNPs after 24 h storage, from 
yellow to black [Figure 3.16]. Furthermore the 1 g/L AgNPs did not absorb after 24 h of 
storage proving complete depletion of the AgNPs after 24 h. The 100 mg/L AgNPs remained 
stable after 24 h of storage at 4 ⁰C [Figure 3.16 (B)].   
A 
B 
100 mg/L    
 
1 g/L 
 
100 mg/L    
 
1 g/L 
 
B 
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3.2.5.2. Concentrating and purification of silver nanoparticles using the Freeze-
dry method 
Following the difficulty in producing a concentrated stock of AgNPs (>100 mg/L), other 
methods such as freeze-drying and centrifugation were undertaken. The Sample BB3 was 
freshly prepared then either centrifuged at 1300 rpm for 30 minutes or freeze dried at -50 °C 
for 120 h as described in section 2.2.2.1 The AgNPs could not be purified by the centrifuge 
method since they remained in suspension [Figure 3.17].  
 
Figure 3.17: Investigating the effect of centrifuge conditions on the AgNPs. 
A) The AgNPs stabilised with citric acid (precipitated). B) AgNPs stabilised with PVP (remained in suspension) 
after the centrifuge step. 
 
The colloidal suspension was successfully freeze-dried to form a black powder of AgNPs.  
The AgNPs were then characterised before and after freeze-drying to investigate the effect of 
freeze-drying on the morphology and size of AgNPs. Figure 3.18 shows the TEM images of 
AgNPs before the [Figure 3.18 (A)] and after [Figure 3.18 (B)] freeze-drying. 
  
 
A B 
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Figure 3.18: Investigating the effect of the freeze-drying conditions on the AgNPs.  
A) The TEM images of AgNPs before the freeze-drying. B) Size distribution of AgNPs before the freeze-drying. 
C) The TEM images of AgNPs after freeze-dying. D) Size distribution of AgNPs after the freeze-drying. 
 
The freeze-dry conditions did not alter the size and morphology of the AgNPs although the 
particle size distribution was slightly affected.  
3.2.6. The assessment of the compatibility of the silver nanoparticles for its 
biological application 
Sample BB3 was freshly prepared and its stability was checked at the bacterial growth 
conditions which included constant shaking the solution at a pH 7.4 for 24 h in a 37 ⁰C 
incubator.  
A B C D
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Figure 3.19: Investigating the effect of bacterial incubation conditions on the AgNPs. 
A) The TEM images of AgNPs before the incubation. B) Size distribution of AgNPs before the incubation. C) The 
TEM images of AgNPs after 24 h incubation. D) Size distribution of AgNPs after the 24 h incubation.  
 
The incubation conditions did not alter the size and morphology of the AgNPs although the 
particle size distribution was slightly affected [Figure 3.19]. 
3.3. Analysis of Silver nanoparticles using EDS  
The EDS analysis of sample BB3 in Table 3.11 shows that there are trace elements in the 
colloidal suspension but these elements were present in such minute concentration that they 
could not be revealed by the EDS spectra. If the background effect of copper and carbon is 
removed a localised EDS analysis predicts 7.22 %, 6.75 %, 5.32 % and 80.69 % of boron, 
oxygen, sodium and silver. 
Table 3. 11: EDS analysis of a localised spot identifyied to be silver nanoparticle . 
Element EDS 
(Weight %) 
EDS 
(Atomic %) 
B 7.22 32.28 
O 6.75 20.38 
A B 
C D 
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3.4 Discussion  
The degree of light absorption and scattering is dependent on the size of the AgNPs. The UV-
visible absorption spectra of all AgNPs synthesised in this study were often symmetric dipole 
resonant modes which indicated the formation of uniform AgNPs, smaller than 50 nm. The 
nanoparticles experienced an uniform electric field because they were smaller than the 
wavelength of light (Gao et al., 2011). If the AgNPs were larger than 50 nm the UV-vis 
spectra would have had an additional shoulder peak called the quadrupolar resonant mode 
(Evanoff & Chumanov, 2004; Kumbhar et al., 2005).  
However, synthesis with the different reducing agent produced nanoparticles of different 
sizes. This uniform electric field deflects with increase in nanoparticle size therefore 
contributing to a Red-shifting towards the visible region and broadening of the spectrum 
(Cao, 2004; Chou et al., 2005). The nanoparticles synthesised by ascorbic acid were bigger 
(absorbing at the wavelength of 430 nm) compared to those synthesised by sodium 
borohydride (absorbing at the wavelength of 390 nm). Sodium borohydride, a strong reducing 
agent, instantly results in ±4 nm seeds; whereas ascorbic acid, a weak reducing agent, has a 
slow rate of formation of new nuclei which allows for rapid aggregation giving rise to a small 
number of large particles (Cao, 2004; Chou et al., 2005; Solomon et al 2007). This was 
observed in the duration and size of AgNPs produced by each synthesis method (ascorbic 
acid or sodium borohydride based). Ascorbic acid needed enough time with silver to 
effectively form AgNPs hence the ascorbic acid synthesis took 30 minute compared to 
sodium borohydride which took a few minutes to complete. Sodium borohydride produced 
Na 5.32 11.19 
Ag 80.69 36.13 
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smaller silver nanoparticles with uniform size and morphology (spherical 6±1.8 nm AgNPs) 
compared to ascorbic acid that produced big particles with a wide size distribution (15±11.15 
nm AgNPs). TEM images showed that both synthesis methods produced spherical AgNPs. 
 Particle maturation was solely controlled by exposure of the AgNPs to light. Stirring AgNPs 
in the light exposure caused particle agglomeration that was not evident in AgNPs that were 
kept stationary. Cao, (2004) explains this phenomenon by stating that small nanoparticles 
(less than 20 nm) have high surface to volume ratio causing them to be more chemically, 
physically and thermodynamically unstable and stirring them enhanced these properties 
resulting in particle agglomeration. These properties on the other hand aided in the formation 
of uniform icosahedral AgNPs (within 6 h), but not stirring AgNP solution resulted in 
different shapes of AgNPs over a longer maturation period (12 hours). 
The synthesised AgNPs should be sustained by the solvents’, protic or aprotic properties 
ionic strength, and polarity, pH and inter-particle interactions to remain stable. The reducing 
agents used in this study, ascorbic acid and sodium borohydride, have high efficacy for the 
reduction of Ag
+
 at alkaline pH, where the zeta potential of silver is around -35 mV. The 
surface charge majorly contributes to the inter-particle forces and can be altered by a certain 
pH. When all particles in suspension are uniformly charged (positively, negative or 
neutrally), they repel each other therefore prevent agglomeration. The silver maximum zeta 
potentials (±35 mV) are estimated to be around pH 2 and pH 10.5 and the point of zero 
charge (pzc) is around pH 5.5 (Overbreek, 1952; Hunter, 1987; Shaw 1992; Larson & Attard, 
2000). In the current study the alkaline reducing agent (sodium borohydride) favoured an 
alkaline stabiliser (PVP) whereas an acidic reducing agent (ascorbic acid) preferred an acidic 
stabiliser (citric acid). Synthesis at point of zero charge (pH 5.5) produces nanoparticles with 
a charge distribution that resembles a bell shape (some negatively charged while others are 
positively charged) therefore the positively and negatively charged particles will be attracted 
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to each other and clump together forming globular structures (Larson & Attard, 2000). This 
phenomenon was evident when the synthesis (both ascorbic acid and sodium borohydride 
based) was controlled at pH 5.5 (pzc), whereas nanoparticles with high zeta potential (pH 9-
10.5) were smaller and more stable. The addition of citric acid as a stabilising agent in the 
sodium borohydride based synthesis altered the pH to around the pzc therefore causing 
agglomeration, but PVP did not alter the pH and resulted in stable, small and uniform AgNPs. 
The opposite was viewed in the ascorbic acid based synthesis.  
The kinetic stabilisation also required a delicate balance in the concentrations of stabilising 
agent for a successful control of size and size-distribution of AgNPs. PVP is a hydrophobic 
polymer that covalently attaches to the surface of the particle. The polymers in the case of 
partially covered particles (low concentration of PVP) tend to interpenetrate in order to 
reduce the unoccupied space between polymers therefore reducing the thickness of the 
stabilising agent protective layer, causing the particles to interact resulting in particle 
agglomeration (Cao, 2004; Travan et al., 2011; Gao et al., 2011). While when particles were 
100% covered (high concentration of PVP) there was minimal to no interaction because the 
distance between the particles was longer than twice the thickness of the stabilising agent 
protective layer, therefore particles repeled each other preventing agglomeration.  
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Chapter 4 
Investigating the antibacterial properties of silver nanoparticles 
4.1. Minimum inhibitory concentration 
Minimum inhibitory concentration (MIC) is defined as the lowest concentration at which 
there is no visible growth. Sample BB3 which produced smaller and uniform AgNPs (6±1.8 
nm) was chosen for the antibacterial study. The silver nanoparticles were prepared by 
reducing silver nitrate with sodium borohydride then stabilising the AgNPs with PVP as 
detailed in section 2.2.2.1.  
There were difficulties in purifying the nanoparticles from by-products such as the sodium 
and boron introduced by the reducing agent compound (NaBH4), the nitrate introduced by the 
silver precursor (AgNO3) and the PVP that coats the nanoparticles. Thus the effect of these 
by-products on bacterial growth was investigated by treating the bacteria with a solution 
containing only the respective amount of by-products expected to be in an AgNPs colloidal 
suspension. To investigate the efficiency of AgNPs over silver ions, bacterial strains were 
treated with AgNO3 at the predicted amount of silver as calculated from the amount in 
AgNPs suspensions. 
Bacterial (B. cereus, C. metallidurans, E. coli 1699, M. smegmatis or S. epidermidis) 
inoculums (at OD ± 0.045) were treated with different concentrations of either by-products or 
Ag
+ 
or AgNPs (0, 10, 20, 30, 40, 50, 60, 70 mg/L) then incubated at 37 ⁰C for 24 h as 
described in section 2.5.2.2. Bacterial growth was determined by measuring turbidity (optical 
density, OD) at 600 nm spectrophotometrically. Lack of turbidity corresponded to either very 
low bacterial growth or complete inhibition. 
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4.1.1. The effect of by-products, silver ions and silver nanoparticles on the 
growth of B. cereus  
Figure 4.1 shows the effect of by-products, silver ions and silver nanoparticles (0 mg/L – 70 
mg/L) on the growth of B. cereus after 24 h incubation. 
 
Figure 4.1: The effect of by-products, silver ions and silver nanoparticles on the growth of B. cereus. 
B. cereus was cultured with or without different concentrations (0-70 mg/L) of by-products, silver ions (Ag
+
), or 
silver nanoparticles (AgNPs) colloidal suspension for 24 h. 
 
Table 4.1 presents the actual effect of AgNPs by deducting the percentage bacterial growth 
inhibition as a result of by-products from the percentage bacterial growth inhibition post 
treatment with AgNPs colloidal suspension.   
Table 4.1: The effect of AgNPs on B. cereus. 
[Ag] mg/L 
Inhibitory 
effect of 
By-
products 
(%) 
Inhibitory 
effect of 
Colloidal 
suspension 
(%) 
Inhibitory 
effect of 
AgNPs (%) 
0 0 0 0 
10 10 12.5 2.5 
20 0 0 0 
30 0 0 0 
40 16.13 18.75 2.62 
50 12.9 0 0 
60 3.23 0 0 
70 17.42 0 0 
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Figure 4.1 showed that by-products, silver ions and silver nanoparticles colloidal suspension 
have no inhibitory effect on the growth of B. cereus. Table 4.1 shows a dose independent 
inhibition following treatment with by-products (in 50, 60 and 70 mg/L AgNPs colloidal 
suspension inhibited the growth of B. cereus by 12.9, 3.23 and 17.42 % respectively) which is 
not evident in the treatment with AgNPs colloidal suspension, suggesting batch to batch 
variation.  
4.1.2. The effect of by-products, silver ions and silver nanoparticles on the 
growth of C. metallidurans 
Figure 4.2 shows the effect of by-products, silver ions and silver nanoparticles (0 mg/L – 70 
mg/L) on the growth of C. metallidurans after 24 h incubation. 
 
Figure 4.2: The effect of by-products, silver ions and silver nanoparticles on the growth of C. metallidurans. 
C. metallidurans was cultured with or without different concentrations (0-70 mg/L) of by-products, silver ions 
(Ag
+
), or silver nanoparticles (AgNPs) in suspension for 24 h. 
 
Table 4.2 presents the actual effect of AgNPs by deducting the percentage bacteria growth 
inhibition as a result of by-products from the percentage bacterial growth inhibition post 
treatment with AgNPs colloidal suspension.   
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Table 4. 2: The effect of AgNPs on C. metallidurans. 
[Ag] mg/L 
Inhibitory 
effect of 
By-products 
(%) 
Inhibitory 
effect of 
Colloidal 
suspension 
(%) 
Inhibitory 
effect of 
AgNPs (%) 
0 0 0 0 
10 20 50 30 
20 25 70 45 
30 30 75 45 
40 32 80 48 
50 35 100 65 
60 40 100 60 
70 42 100 58 
 
C. metallidurans showed a dose dependent growth inhibition following treatment with by-
product. The by-product in 10, 20, 30, 40, 50, 60 and 70 mg/L AgNPs suspension reduced the 
growth of C. metallidurans by 20, 25, 30, 32, 35, 40 and 42 % respectively. Although the 
bacterium was sensitive to the by-products, more inhibition was evident when treating with 
AgNPs colloidal suspension. C. metallidurans growth inhibition in the presence of silver 
nanoparticles also showed a dose dependent pattern. Ten milligram per litre AgNPs reduced 
50 % of C. metallidurans within 24 h incubation. The bacterial growth gradually decreased 
by 75, 85 and 90 % when the bacterium was exposed to 20, 30 and 40 mg/L AgNPs colloidal 
suspension respectively. C. metallidurans was completely eradicated by 50 mg/L AgNPs in 
suspension which was then determined to be the MIC [Figure 4.2]. AgNPs in the absence of 
by-products also showed a dose dependent inhibitory effect on C. metallidurans [Table 4.2]. 
Silver nanoparticles inhibited C. metallidurans in a manner where 10, 20, 30, 40, and 50 
mg/L AgNPs reduced 30, 45, 45, 48, and 65 % of the bacteria after 24 h incubation [Table 
4.2]. C. metallidurans was completely inhibited by low concentration of silver ions (10 
mg/L). 
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4.1.3. The effect of by-products, silver ions and silver nanoparticles on the 
growth of E. coli  
Figure 4.3 shows the effect of by-products, silver ions and silver nanoparticles colloidal 
suspension (0 mg/L – 70 mg/L) on the growth of E. coli after 24 h incubation.  
 
Figure 4.3: The effect of by-products, silver ions and silver nanoparticles on the growth of E. coli. 
E. coli  was cultured with or without different concentrations (0-70 mg/L) of by-products, silver ions (Ag
+
), or 
silver nanoparticles (AgNPs) in suspension for 24 h. 
 
Table 4.3 presents the actual effect of AgNPs on E. coli, by deducting the percentage bacteria 
growth inhibition due to by-products from the percentage bacterial growth inhibition post 
treatment with AgNPs colloidal suspension.   
Table 4.3: The effect of AgNPs on E. coli. 
[Ag] 
mg/L 
Inhibitory 
effect of 
By-products 
(%) 
Inhibitory 
effect of 
Colloidal 
suspension 
(%) 
Inhibitory 
effect of 
AgNPs (%) 
0 0 0 0 
10 11.76 29.41 17.65 
20 17.64 100 82.36 
30 18 100 82 
40 20.59 100 79.41 
50 38.24 100 61.76 
60 46.7 100 53.3 
70 50 100 50 
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The treatment with by-product solution inhibited E. coli growth in a dose dependent manner. 
The by-products in 10, 20, 30, 40, 50, 60 and 70 mg/L AgNPs suspension reduced the growth 
of E. coli by 11.76, 17.64, 18, 20.59, 38.24, 46.7 and 50 % respectively. Nevertheless the 
bacterium was more sensitive to AgNPs colloidal suspension, meaning that the silver 
nanoparticles had an adverse effect on E. coli. Ten-milligram AgNPs in suspension was 
successful in inhibiting 29.41 % of the bacteria and the increase of concentration to 20 mg/L 
resulted in complete inhibition of E. coli growth. The MIC of 20 mg/L AgNPs colloidal 
suspension was mostly a result of AgNPs (82.36 %) since the by-product could only account 
for 17.64 % growth inhibition [Table 4.3]. Low concentrations of silver ions (10 mg/L) 
inhibited the growth of E. coli completely. 
4.1.4. The effect of by-products, silver ions and silver nanoparticles on the 
growth of M. smegmatis 
Figure 4.4 shows the effect of by-products, silver ions and silver nanoparticles (0 mg/L – 70 
mg/L) upon the growth of M. smegmatis after 24 h incubation. 
 
Figure 4.4: The effect of by-products, silver ions and silver nanoparticles on the growth of M. smegmatis.  
M. smegmatis was cultured with or without different concentrations (0-70 mg/L) of by-products, silver ions 
(Ag
+
), or silver nanoparticles (AgNPs) in suspension for 24 h. 
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Table 4.4 shows the actual effect of AgNPs on the growth of M. smegmatis, by deducting the 
percentage bacteria growth inhibition due to by-products from the percentage bacterial 
growth inhibition post treatment with AgNPs in suspension.   
Table 4.4: The effect of AgNPs on M. smegmatis. 
[Ag] mg/L 
Inhibitory 
effect of 
By-products 
(%) 
Inhibitory 
effect of 
Colloidal 
suspension 
(%) 
Inhibitory 
effect of 
AgNPs (%) 
0 0 0 0 
10 0 26.92 26.92 
20 10.71 32.69 21.98 
30 7.15 42.31 35.16 
40 8.57 53.85 45.28 
50 14.29 51.92 37.63 
60 21.43 53 31.57 
70 7 50.5 43.5 
 
By-products showed no significant inhibitory effect on the growth of M. smegmatis with 
respect to the untreated cells (0 mg/L). Table 4.4 shows that M. smegmatis has a dose 
independent sensitivity to the by-products. On the other hand, AgNPs showed a dose 
dependent inhibition of 26.92, 21.98, 35.16, 45.28, 37.63, 31.57 and 43.5 % bacterial growth 
when treated with 10, 20, 30, 40, 50, 60 and 70 mg/L AgNPs respectively. Silver ions were 
successful in maintaining the growth of M. smegmatis at low cell numbers, at OD=0.08-0.1, 
this poses a risk of the bacteria resisting the silver, recuperating and multiplying. 
4.1.5. The effect of silver nanoparticles, by-products and silver ions on S. 
epidermidis 
Figure 4.5 shows the effect of silver nanoparticles, by-products and silver ions (0 mg/L – 70 
mg/L) in the growth of S. epidermidis after 24 h incubations.  
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Figure 4.5: The effect of by-products, silver ions and silver nanoparticles on the growth of S. epidermidis.   
S. epidermidis  was cultured with or without different concentrations (0-70 mg/L) of by-products, silver ions 
(Ag
+
), or silver nanoparticles (AgNPs) in suspension for 24 h. 
 
Table 4.5 presents the actual effect of AgNPs on the growth of S. epidermidis, by deducting 
the percentage bacteria growth inhibition due to by-products from the percentage bacterial 
growth inhibition post treatment with AgNPs in suspension.   
Table 4.5: The effect of AgNPs on S. epidermidis. 
[Ag] mg/L 
Inhibitory 
effect of 
By-products 
(%) 
Inhibitory 
effect of 
Colloidal 
suspension 
(%) 
Inhibitory 
effect of 
AgNPs (%) 
0 0 0 0 
10 0 0 0 
20 0 0 0 
30 24 0 0 
40 24 25 1 
50                 27 26 0 
60 28 25 0 
70 27 26 0 
 
S. epidemidis showed a dose dependent sensitivity to the by-product. Table 4.5 illustrated that 
AgNPs had not inhibitory effect rather the inhibition presented in Figure 4.1 results from the 
by-products in the colloidal suspension. However, S. epidermidis was sensitive to silver ions. 
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Ten milligram per litre of silver ions reduced 50 % of S. epidermidis after 24 h incubation. 
The increase of Ag
+
 concentration from 30 to 70 mg/L inhibited only 55 % of the bacterial 
growth.  
4.2. Growth retardation patterns of bacteria treated with silver 
nanoparticles 
Bacterial growth is a measure of increase in cell mass resulting from cell replication or 
increase in cell size. The bacteria grows in sigmoidal shape (growth curve) with a lag phase 
(bacteria adapts to new environment, minimal cell division, maximum metabolism, synthesis 
of RNA, proteins and other metabolites), log phase (exponential cell division), stationary 
phase (depletion of nutrients and accumulation of wastes products cell growth rate equals 
death rate) and death phase (Lodish et al., 2000; Staropoli & Alon, 2000; Al-Qadiri et al., 
2008). As such bacterial growth inhibition at one of these phases following treatment with 
AgNPs denotes the mode of action of the nanoparticles. 
As shown above B. cereus and S. epidermidis were resistant to AgNPs treatment, whilst M. 
smegmatis showed sensitivity to AgNPs although the MIC was not established. On the 
contrary E. coli and C. metallidurans showed sensitivity to AgNPs and the MICs were 
established at 20 mg/L and 50 mg/L AgNPs in colloidal suspension respectively. The 
antibacterial effect of AgNPs was further characterised on E. coli and C. metallidurans as 
described in section 2.5.2.3. Figure 4.6 shows the growth patterns of C. metallidurans and E. 
coli, untreated and treated with AgNPs.  
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Figure 4.6: Effect of AgNPs on the growth C. metallidurans and E. coli.    
A) C. metallidurans was treated with 0, 10 and 50 mg/L AgNPs and grown at 37 °C in casamino acid- peptone 
glucose media. B) E. coli was treated with 0, 10 and 20 mg/L AgNPs and grown at 37 °C in Lubria broth.  
 
Table 4.6 shows the bacterial growth rates of E. coli and C. metallidurans following 
inoculation with AgNPs. 
Table 4.6: The bacterial growth rate following exposure to AgNPs.  
 
The untreated C. metallidurans cells had a short lag phase of 4 h and a log phase that lasted 8 
h (with cells multiplying every 1.5 hours) prior to the stationary phase at approximately 12 h 
of incubation. The treatment with 10 mg/L AgNPs reduced the growth of C. metallidurans by 
up to 50 %. The cells treated with 10 mg/L AgNPs had a prolonged lag phase (from 4 h of 
untreated compare to 12 h when cells were treated with 10 mg/L AgNPs). The untreated cells 
had a growth rate of 1.5 h and treating with 10 mg/L AgNPs slowed the doubling time to 6 h. 
Gradually increasing the concentration of AgNPs by 10 mg/L consistently slowed the growth 
rate of C. metallidurans by ±4 h. Treatment with 50 mg/L AgNPs completely inhibited 
growth, confirming this to be the MIC. 
The untreated E. coli cells had a lag phase that lasted 1.5 h while the log phase lasted for 5 h 
prior to the commencement of the stationary phase after 6 h of incubation. The cells treated 
with 10 mg/L AgNPs prolonged the lag phase to 8 h compared to the lag phase of the 
[AgNPs] (mg/L) 0 10 20 30 40 50 
Growth rate of C. metallidurans (h) 1.5 6 10 14 16 MIC 
Growth rate of E. coli (h) 1 3 MIC 
   
A B 
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untreated cells (1.5 h).  The lag phase of the E. coli cells treated with AgNPs showed a sharp 
decline in bacterial density (absorbance) which denoted immediate cidal effects. The 
untreated cells had a growth rate of 1 h whereas the growth rate of cells treated with 10 mg/L 
AgNPs was 3 h [Table 4.6].  The treatment with 10 mg/L AgNPs reduced the growth of E. 
coli by up to 50 %. The cells that were treated with 20 mg/L AgNPs were completely 
eradicated proving this concentration to be the MIC. 
4.3. TEM characterisation of the morphological alterations caused by 
silver nanoparticles on E. coli  
Silver nanoparticles (6±1.8 nm) stabilised with PVP were freshly prepared as detailed in 
section 2.2.2. E. coli was allowed to grow until mid log phase (OD = 0.4) and subsequently 
the bacterial culture was treated with 20 mg/L AgNPs and allowed to grow for 1 h prior to 
harvesting for TEM analysis as described in section 2.6. Figure 4.7 shows the transmission 
electron micrographs of E. coli cells grown in LB media at 37 ⁰C then treated at mid log 
phase (OD = 0.4) with 20 mg/L AgNPs and then harvested an hour later.  
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Figure 4.7: Transmission electron micrographs of E. coli. 
A) E. coli grown in LB media and harvested at mid log phase (OD = 0.4). B) A healthy (untreated) E. coli cell at 
log phase. C) E. coli grown in LB media then treated with 20 mg/L AgNPs at mid log phase and harvested after 
an hour. D) E. coli distorted by AgNPs.  
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Figure 4.8: Transmission electron micrographs of E. coli treated with 20 mg/L AgNPs. 
A) Detaching of the cytoplasmic membrane from the cell wall. B) Accumulation of AgNPs within the bacterial 
cell. C) Cell leakage. D) Cell leakage. 
 
The black spots within the cells [Figure 4.8 (B)] were analysed using localised EDS coupled 
to TEM, as described in section 2.4.3. Figure 4.9 shows the EDS spectra of the black spot 
within the E. coli cells following treatment with 20 mg/L AgNPs. 
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Figure 4.9: The localised EDS spectra E. coli. 
A) EDS spectrum of the dark spots accumulating inside the E. coli cell. B) EDS spectrum taken at a region away 
from the dark spots accumulating inside the E. coli cell. 
 
A 
B 
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The cells treated with AgNPs showed distorted morphology such as: cytoplasm membrane 
detachment from the cell wall (depicting cell shrinkage) [Figure 4.7 D] and elongated cells 
with septa containing a layer of un-split peptidoglycan (depicting impairment cell division) 
[Figure 4.7 C compared to Figure 4.7 A]. Figure 4.8 presented cell compartments of untreated 
cells such as the cell membrane, cell wall, ribosome, nucleoid as intact, whereas the cells 
treated with 20 mg/L AgNPs resulted in cell shrinkage with the cell membrane detached from 
the cell wall.. Figure 4.8 C & D showed leakage E. coli cellular components following the 
treatment with AgNPs. The EDS analysis of the dark spots (45±11 nm AgNPs) within E coli 
cells [Figure 4.8 B] proved that nanoparticles accumulated the cells. Figure 4.9 showed EDS 
spectra that presented with carbon (C) and oxygen (O) which are components of the cell. The 
cells were stained by lead citrate (Pb3(C6H5O7)2), hence the presence of lead is abundant. 
There is a distinct peak of copper (Cu) since the analysis was carried out on a copper grid. 
The EDS localised to the dark spots [Figure 4.9 (A)] presented with silver X-rays around 3.4 
KeV which were absent in Figure 4.9 (B). The X-rays however were not enough to produce a 
distinct peak because they were surpassed by the other elements present in high quantities.    
4.4. Discussion   
Previous studies have reported that smaller AgNPs demonstrated stronger antibacterial 
effects, than bigger particles and mostly surpass silver ions (Morones et al., 2005; Choi & 
Hu, 2008). However, in the current study silver ions were more toxic than the silver 
nanoparticles synthesised. The MIC as a result of silver ions was established to be 10 mg/L 
Ag
+
 for C. metallidurans, E. coli and M. smegmatis whereas MIC as a result of silver 
nanoparticles was 50 mg/L and 20 mg/L AgNPs for C. metallidurans and E. coli respectively. 
M. smegmatis showed sensitivity to the AgNPs however a small population of the bacteria 
survived this poses a risk of the bacteria resisting the silver, recuperating and multiplying. 
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The bacterial strain that showed sensitivity to silver ions also responded to the treatment with 
AgNPs, supporting literature which states that the mode of action of AgNPs involves, but is 
not limited to, Ag
+
 mode of action (Morones et al., 2005; Šileikaite et al., 2006). The low 
toxicity resulting from the treatment with AgNPs compared to the treatment with silver ions 
could be because of the delay caused by leaching of Ag
+
 from AgNPs (oxidation of AgNPs 
from zero valent silver to silver ions) therefore delaying the Ag
+ 
mediated mode of action.  
The current study is in accordance with literature that gram positive bacteria (B. cereus and S. 
epidermidis) or those with an acid fast cell wall (M. smegmatis) were resistant to the AgNPs, 
compared to gram negative bacteria (E. coli and C. metallidurans) (Morones et al., 2005; Cho 
et al., 2005; Kim et al., 2007). The complexity of the cell wall aided in the resistance of the 
bacteria to the by-products, silver nanoparticles and silver ions. The peptidoglycan layer of 
gram positive bacteria is thicker than that of gram negative bacteria, therefore offering more 
protection to the cell (Jung et al., 2008). M. smegmatis resistance of these conditions may 
result from the acid fast bacterial cell wall. 
In contrast, Ruparelia et al., (2008) demonstrated that some gram negative bacterial strains 
(E. coli MTCC 739 and MTCC 1687) were much more resistant than gram positive bacteria 
(S. aureus). Therefore it cannot be concluded that the bactericidal effect of nanoparticles is 
solely dependent on the structure of the bacterial cell wall. In addition, the ability of B. cereus 
to resist silver was explained by Mullen et al., (1989), where B. cereus was grown in the 
presence of 1 mM AgNO3. It was discovered that some B. cereus strains are involved in 
bioremediation and detoxification of silver. The strains reduced 89 % of silver ions to 
uncharged silver and produced colloidal aggregates that accumulated on the cell surface and 
occasionally in the cytoplasm (Mullen et al., 1989; Ganesh Badu et al., 2009).  Other Bacillus 
species have also been reported to produce precipitated silver aggregates (nanoparticles) such 
as B. licheniformis (Beveridge et al., 1982; Kalishwaralal et al., 2008), B. cereus PGN1 
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(Ganesh Babu et al., 2009), B. subtilis (Beveridge et al., 1980) but the mechanism of this 
reaction is not yet clear. These findings predict that the B. cereus strain used in this study is 
highly resistant, thus rendering AgNPs as an antimicrobial agent inefficient. 
S. epidermidis was sensitive to the Ag
+
 but the MIC could not be established. Cho et al., 
(2005) reported that the mode of action of Ag
+ 
involves attachment of Ag
+
 to the surface of 
the bacteria and interaction with the bacterial proteins. The steady bacterial growth, 
irrespective of the increase in concentration, could mean that the binding or interaction sites 
of silver on S. epidermidis cells were saturated by concentrations as low as 10 mg/L Ag
+
 so 
the increase in concentrations to 70 mg/L Ag
+
 did not have an acumulative effect.  
Even though there has not been reported resistance incidences in environments where silver 
is routinely used; such as, burns units in hospitals, silver-coated catheters and dental setting 
(amalgams contain 35% silver), the resistance shown by B. cereus and S. epidermidis poses 
the possibility of the emergence of resistant strains.  
The bacterial growth curves revealed a prolonged lag phase on the growth of E. coli and C. 
metallidurans following treatment with AgNPs which was consistent with the results 
published in Ruparelia et al., (2008), where they observed a longer lag phase following 
treatment of bacteria with AgNPs. They elaborated that a longer lag phase marked the 
inhibition of cell metabolism, RNA and protein synthesis (Ruparelia et al., 2008).  
The TEM images showed cell shrinkage and leakage of cellular components. Following the 
attachment of the nanoparticles, Gade et al., (2008) also observed disruption of the bacterial 
membrane causing leakage and ultimately cell death. Feng et al., (2000) also examined the 
morphological damaged in E. coli cell treated with silver species, using electron microscopy 
(TEM and SEM) and X-ray microanalyses. They reported similar morphological changes 
such as cytoplasm membrane detachment from the cell wall and impairment of DNA 
replication.  The cellular leakage in Figure 4.8 C & D were similar to the ones determined in 
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literature to be condensed deoxyribonucleic acid (DNA) molecules that protect nucleic acid 
from silver ion mediated damage (Feng et al., 2000). Jung et al., (2008) treated the cells with 
silver ions and reported similar cell morphological changes. These bacterial cells remained 
active but in a non-culturable state and eventually died.  
The TEM images also showed elongated cells, depicting similar outcomes as shown in a 
study by  Uehara et al., (2009), who found that an E. coli mutant that did not express LytM 
(lysostaphin)-domain containing factors would prepare for cell division but form long cell 
chains with septa containing a layer of un-split peptidoglycan. This led to the assumption that 
AgNPs mode of action involved cell division suppression.  
The TEM images and EDS analysis showed that E. coli cells accumulated the nanoparticles 
forming 45±11 nm AgNPs agglomerates, whereas the nanoparticles incubated in growth 
media in the absence of bacteria for 24 h (in rotary shaker) did not change shape or size. This 
is in line with a study by Ruparelia et al., (2008) which concluded that salts and nutrients did 
not cause particle agglomeration, rather they facilitated the release of Ag
+
 into the media. 
Therefore the AgNPs interact with the bacterium which interferes with the stabilising agent 
later resulting in particle agglomeration. Feng et al., (2000) also observed electron-dense 
granules (identified to contain silver and sulfur) that were surrounding the cell wall and some 
deposited inside the cells, such as the ones identified in the current study using EDS as silver 
nanoparticles [Figure 4.9]. The AgNPs accumulated in the cytoplasm and in the vicinity of 
the cell membrane. Morones et al., (2005), Gade et al., (2008) and Raffin et al., (2008) also 
discovered a size dependent particle penetration and the localization of particles in the 
ribosome and nucleoid region, which estimates AgNP’s mode of action with cellular 
metabolism and replication impairment.  
Nanda et al., 2009 reported that Methicillin resistant Staphylococcus aureus (MRSA), 
Methicillin resistant Staphylococcus epidermidis (MRSE) and Streptococcus pyogenes were 
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sensitive to silver nanoparticles. The current study also showed that E. coli 1699 which is 
resistant to a wide range of antibiotics showed sensitivity towards AgNPs. 
Literature supports that particles with sizes between 1-10 nm have a greater antibacterial 
activity since they have a larger surface to volume ratio (Baker et al., 2005; Panacek et al., 
2006; Mohan et al., 2007; Choi et al., 2008). The current study contradicts this statement as 
the MIC as a result of 6±1.8 nm AgNPs was higher than that which was reported in a study 
by Kim et al., (2007) who used  13.5 ± 2.6 nm (3 nmol L
-1
) AgNPs to completely inhibit the 
growth of E. coli. However, some studies define MIC as the concentration of the antibacterial 
agent that has the ability to inhibit the growth of bacteria and the minimum bactericidal 
concentration (MBC) as the concentration of the antimicrobial agent that can inhibit 99.9 % 
of bacterial growth. Studies conducted on agar plates have generally had a higher MIC than 
liquid cultures (Morones et al., 2005). AgNPs are highly unstable and this instability 
increases with a decrease in size, hence different synthesis methods produce nanoparticles 
with or without an oxide and the layer of stabilising agent. Literature showed that these outer 
layers can interfere with the antibacterial efficacy. Ruparelia et al., (2008) revealed that 
nanoparticles with an oxide layer produce more ions and have a greater cidal effect compared 
to nanoparticles without the oxide layer. Cho et al., (2005) reported that PVP coated AgNPs 
were more toxic than those coated with sodium dodecyl sulfate (SDS), even though SDS 
produces a more stable suspension and concluded that stabilising agents have a tendency to 
interfere with Ag
+
 release or attachment to the bacterial surface. Irwin et al., (2010) 
investigated the effect of stabilising agents on the efficacy of silver nanoparticles as an 
antimicrobial agent and came to the conclusion that the PVP layer disrupts the nanoparticle-
bacteria interaction therefore decreasing the antimicrobial efficacy. Cho et al., 2005 
investigated the effect of 8–15 nm AgNPs on E. coli and found that SDS-stabilised AgNPs 
did not have antibacterial effects whereas 100 ppm AgNPs coated with PVP eradicated both 
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gram positive and gram negative bacteria within 4 hours. The chemical studies showed that 
SDS had better stabilizing properties compared to PVP, and the chemically stable AgNPs 
showed no antibacterial activity (Cho et al., 2005).  
The effect of the by-product enhanced the effect of the AgNPs, since the bacterial strains that 
were sensitive to the by-product also showed sensitivity to AgNPs in suspension. Half of C. 
metallidurans and E. coli population was eradicated by 10 mg/L AgNPs in suspension and 
the impurities in the 10 mg/L AgNPs suspension accounted for 30 % and 11 % of the growth 
inhibition of C. metallidurans and E. coli respectively. B. cereus displayed resistance to the 
treatments with by-products as well as AgNPs. In contrast, Kim et al., (2007) conducted a 
similar study with AgNPs synthesised with sodium borohydride and tested their effect on E. 
coli and S. aureus. They designed their control by agglomerating the AgNPs by vigorous 
stirring and they concluded that the by-products of the AgNPs synthesis did not have 
significant cidal effect on both strains. The chemical synthesis of metallic nanoparticles can 
produce stable particles of controlled size and distribution although the purity is 
compromised by the by-products of the synthesis. Hence, it is necessary to find an absorbent 
such as zeolites to purify the colloidal suspensions of contaminants. Zeolites have the ability 
to bind ions and are microparticles in nature which could allow for the purification of 
nanoparticles by size (Galeano et al., 2003).  
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Chapter 5 
Conclusions and Future Prospects 
5.1. The conclusion drawn from the present investigations are as follows: 
The present study synthesised small, stable and uniformly dispersed silver nanoparticles. 
AgNPs were synthesized successfully by chemical reduction of silver nitrate using ascorbic 
acid and sodium borohydride as reducing agents. The formation of AgNPs was confirmed by 
UV-vis spectroscopy and TEM coupled with EDS. The average particle size was found to be 
15.4±11.15 nm and 6±1.8 nm, for ascorbic acid and sodium borohydride synthesises 
respectively. Varying the amount of reducing agent had not significant effect on the particle 
size; however it improved the particle size distribution in the sodium borohydride synthesis. 
The present study found that small AgNPs were highly unstable and agglomerated within 24 
hours if not stabilised, however the addition of stabilising agent caused a slight increase in 
particle size. Citric acid stabilised the AgNPs synthesised through ascorbic acid oxidation 
whereas PVP favoured the stability of AgNPs synthesised through sodium borohydride 
oxidation. Increasing pH showed a significant increase in particle size and narrowed the 
particle size distribution. Light was the only parameter that changed the shape of the AgNPs. 
The optimum processing conditions that produced 6±1.8 nm spherical nanoparticles included 
maintaining the temperature at 0 ⁰C, the pH at 9.78 and the NaBH4/Ag/PVP ratio at 16:1:10. 
Then the antibacterial efficiency of the AgNPs was investigated on Cupriavidus 
metallidurans, Staphylococcus epidermidis, Mycobacterium smegmatis, Bacillus cereus and a 
multi-drug resistant Escherichia coli 1699. Gram-positive (B. cereus and S. epidermidis) and 
acid fast bacteria (M. smegmatis) showed resistance or tolerance toward the AgNPs compared 
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to a Gram-negative bacterium (E. coli and C. metallidurans). B. cereus was completely 
resistant whereas M. smegmatis and S. epidermidis tolerated the AgNPs. The MIC for E. coli 
and C. metallidurans was established to be 20 mg/L and 50 mg/L respectively. When the 
result was compared with the effect of silver ions on all bacterial strains, nanoparticles were 
found to be less toxic. This contradicted the literature which states that nanoparticles are 
more toxic than silver ions (Morones et al., 2005); but it is also established that stabilizing 
agents compromised the antibacterial efficacy of the nanoparticles.  The TEM coupled with 
EDS showed accumulation of AgNPs inside the E. coli cells grown in presence of AgNPs. 
However, the mode of binding and entry could not be established. The AgNPs treated cells 
presented with cell shrinking, cell leakage and retarded cell division. 
Although there has not been any reported clinical incidence of silver resistance, following 
increased number of silver-based products in the environment and the large number of 
bacterial strains that are not sensitive to silver nanoparticles resistance can emerge. The WHO 
requires an antimicrobial agent to inhibit a wide range of microorganisms at concentrations 
that will not be harmful to the environment. Therefore implementation of chemically 
synthesised AgNPs-based water treatment methods would not be ecologically sound since 
this antimicrobial agent could not eradicate all microorganisms at the maximum 
concentration that a human body can take (100 mg/L).   
5.2. The present study encountered the following limitations: 
 Only a single set of stable (PVP), small, uniformly distributed and spherical AgNPs 
were used to investigate the antimicrobial properties of the AgNPs. A comparative 
study of the antimicrobial effect of unsterilized, large, different sized or shaped 
AgNPs would have drawn a substantial conclusion.  
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 As the antimicrobial activity of the AgNPs were performed on a few strains (C. 
metallidurans, S. epidermidis, M. smegmatis, B. cereus and E. coli)  under similar 
conditions and at commencement of lag phase, the results might be different for other 
microorganisms under different conditions. However, the results obtained in this 
study can be used as a model for other microorganisms.  
5.3. The present research work leaves the following future prospects:  
 This study has provided the basis for investigating further the attractive features of 
AgNPs as antimicrobial, antibacterial, antiviral and antifungal agents. 
 The mechanism of antimicrobial action presented in this work can be validated by 
performing flow cytometry and FTIR analysis. In addition the surface location of 
silver on the bacteria can be analyzed by HR-TEM or SEM a better understanding of 
the mode of antimicrobial activity of silver.  
 More research needs to be done to improve specificity and selectivity of the 
nanoparticles in order to have a discriminative bacterial cidal effect; such as exploring 
AgNPs synthesis methods that do not produce by-products or find ways to purify the 
by-products that might be toxic to human beings and the environment.  
 The nanoparticles couldn’t be synthesised at high concentrations (1g/L) because they 
showed agglomeration even in the presence of a stabilising agent. So other forms of 
concentrating AgNPs such as ultra centrifuge should be explored.  
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